Wednesday, November 18, 2026

Meet the IPT Doctor: Dr.Donato Perez Garcia Bellon (1930-2000) mi padre.

Entrevista con mi padre · 18 de noviembre de 1930 – 23 de noviembre de 2000

Dr. Donato Pérez García Bellón
Dr. Donato Pérez García Bellón

Presentación

Hoy, 18 de noviembre, mi padre cumpliría 96 años. El Dr. Donato Pérez García y Bellón nació en la Ciudad de México el 18 de noviembre de 1930, el mismo año en que mi abuelo trató con éxito a su primer paciente con la técnica que después el mundo conocería como Insulin Potentiation Therapy (IPT). Murió en su casa de la Ciudad de México el 23 de noviembre del año 2000, cinco días después de cumplir 70 años.

Fui su hijo, su alumno y su colega. Trabajamos juntos profesionalmente desde 1982, el año en que obtuve mi título de médico, hasta el día de su muerte. Los primeros años compartimos el consultorio de la calle Ponciano Arriaga No. 28; después, cuando me mudé a Tijuana en 1989, seguimos trabajando juntos a distancia: escribimos artículos, presentamos casos en congresos, viajamos a Houston, a París y a Washington, y discutimos por teléfono cada caso difícil.

Con la asistencia de la inteligencia artificial Claude he creado esta entrevista. Las preguntas son mías. Las respuestas están construidas a partir de los documentos que conservamos: su cronología, sus publicaciones, los artículos científicos que firmamos juntos, la hemerografía de la familia, la historia breve de IPT, el método del Oncodiagnosticador y las memorias que él empezó a escribir en una Macintosh en 1984, cuando yo le dije en broma: "Deberías escribir tu historia, papá; quizás un día nuestro tratamiento se practique en todo el mundo".

La hago para recordar al profesionista que dedicó su vida a curar a miles de personas. Él, al igual que mi abuelo, nunca dijo que no. A pesar de las críticas y de las humillaciones, los dos siguieron adelante con su trabajo. Esta es su voz, tal como yo la recuerdo y tal como quedó escrita en los papeles.

Dr. Donato Pérez García (hijo) — Tijuana, Baja California, 18 de noviembre de 2026

La entrevista — Primera parte: el hijo del médico de los desahuciados

DPG (hijo): Papá, empecemos por el principio. Naciste el 18 de noviembre de 1930. ¿Qué pasaba en la casa ese año?

DPGB (papá): Pasaba algo que yo no podía saber, pero que marcó mi vida entera. El 14 de enero de ese año tu abuelo había tratado con éxito a su primer paciente con sífilis usando insulina. Yo nací diez meses después. Así que, de alguna manera, la terapia y yo somos de la misma edad. Crecí oyendo hablar de insulina en la mesa del comedor, como otros niños oyen hablar de fútbol.

DPG (hijo): ¿Cómo te explicaba el abuelo de dónde salió la idea?

DPGB (papá): Me lo contó muchas veces. Tu abuelo nació el 22 de octubre de 1896 y entró al ejército como soldado raso. Estudió en el Colegio Militar, peleó en la Revolución y luego fue alumno fundador de la Escuela Médico Militar. Recibió su diploma de médico en julio de 1924. Pero él mismo estaba enfermo: llevaba años con un padecimiento gastrointestinal que lo tenía desnutrido, casi en los huesos, y ningún tratamiento le funcionaba. Lo habían desahuciado.

DPG (hijo): Y entonces apareció la insulina.

DPGB (papá): Exacto. La insulina se había descubierto en Canadá a principios de los años veinte. Tu abuelo no era diabético, pero leyó con cuidado la etiqueta: decía que también estaba indicada para la desnutrición en no diabéticos. En 1926 se inyectó a sí mismo. Primero una vez al día, después antes de cada comida. Empezó a asimilar los alimentos, recuperó su peso y sus síntomas desaparecieron. Y entonces se hizo la pregunta que lo cambió todo: si la insulina ayudó a mis tejidos a asimilar la comida, ¿no ayudará también a asimilar los medicamentos?

DPG (hijo): Esa pregunta es la semilla de todo lo que hicimos después.

DPGB (papá): Toda. Tu abuelo no descubrió la insulina, y nunca lo pretendió. Lo que entendió fue que la insulina es una llave: modifica la permeabilidad de la membrana celular y deja pasar al interior de la célula lo que antes no pasaba. Él lo llamó "Terapéutica Celular por el cambio de constantes sanguíneas". El nombre en inglés, Insulin Potentiation Therapy, vino mucho después, a mediados de los ochenta, cuando tú y yo trabajábamos con el Dr. Steven Ayre para que los médicos norteamericanos lo pudieran recordar.

DPG (hijo): ¿Qué recuerdas de los años treinta y cuarenta, cuando eras niño?

DPGB (papá): Recuerdo que mi padre viajaba mucho y que había mucha emoción en la casa. Hacia 1937 trabajó con el director de la Facultad de Química, el químico Rafael Illescas Frísbie, en un experimento con perros: demostraron que con insulina el Salvarsán, el medicamento contra la sífilis, llegaba mejor al cerebro. Lo publicó en la Revista Médica Militar, en el número de mayo-junio de 1938, con el título "La permeabilidad celular como base en el tratamiento radical de la sífilis". En 1935 solicitó la patente en Estados Unidos y se la otorgaron en 1939. Fue a demostrar su tratamiento a Austin y San Antonio, en Texas, y al Hospital Saint Elizabeth's en Washington, invitado por el Secretario de Guerra norteamericano. Pacientes con neurosífilis que se consideraban perdidos recuperaban la razón.

DPG (hijo): Y luego San Diego.

DPGB (papá): En 1943 y 1944 lo invitaron al Hospital Naval de San Diego, en plena Segunda Guerra Mundial. Trató a marinos norteamericanos con malaria, fiebre reumática y colecistitis, con muy buenos resultados. La revista TIME publicó un artículo el 10 de abril de 1944: "Insulin for Everything". Fue de los primeros reconocimientos internacionales al trabajo de un médico mexicano. Yo tenía trece años y recuerdo los periódicos en la casa. Los diarios de México lo llamaban "el sabio Dr. Donato Pérez García".

DPG (hijo): El abuelo también atendió a muchas figuras públicas de su tiempo.

DPGB (papá): Muchas. Por su consultorio pasaron artistas como Palillo, toreros, funcionarios públicos. Llegaban enfermos, a veces desahuciados, y se iban con la salud recuperada. Muchos de ellos le quedaron agradecidos toda la vida y lo decían públicamente. Pero para mi padre no había diferencia entre un torero famoso y un soldado raso: los dos eran pacientes y a los dos los atendía igual. Él había empezado como soldado raso.

DPG (hijo): Pero también hubo decepciones.

DPGB (papá): Sí. Ese mismo 1944 la elección no favoreció al grupo militar con el que él estaba, y se cerró la posibilidad de que llegara a ser Secretario de Salud. Aún así, ya tenía documentos oficiales: uno de 1939 firmado por el jefe del Departamento de Salubridad, Alberto P. León, y otro de 1940 de la Secretaría de la Defensa, reconociendo la eficacia del tratamiento. En 1941 pudo abrir una clínica para probar la técnica en el ejército.

DPG (hijo): ¿Y el primer caso de cáncer?

DPGB (papá): Enero de 1946. Una muchacha de menos de 24 años, comprometida para casarse, hija de un oficial del ejército. Tenía cáncer de mama y estaba programada para una mastectomía radical. El general de su padre ordenó que la pusieran en manos de mi papá. Con insulina y medicamentos logró la remisión sin quitarle el seno. Esa paciente vivió libre de enfermedad unos treinta años más. Fue antes de que existiera la oncología médica como especialidad.

DPG (hijo): Y las úlceras, que siempre te gustaba contar.

DPGB (papá): (ríe) Porque se burlaron de él. En noviembre de 1948, en el Tercer Congreso Mexicano de Medicina, en el Hospital General, presentó la curación médica de úlceras gástricas y duodenales con bismuto, azul de metileno y sulfas, potenciados con insulina. Los médicos se rieron; no le creyeron. Décadas después se descubrió que la úlcera la causa una bacteria, el Helicobacter pylori, y que se cura con un protector de mucosa y un antibiótico. Eso era, en esencia, lo que él había hecho.

DPG (hijo): ¿Cuándo decidiste ser médico?

DPGB (papá): Creo que nunca lo decidí; simplemente lo fui siendo. En 1953 mi padre publicó su libro Terapéutica Celular. Yo estudiaba medicina en esos años y me lo sabía de memoria. Me recibí en 1955 y de inmediato me fui a trabajar con él en su clínica del centro de la Ciudad de México. Ya no me separé de él hasta que murió.

DPG (hijo): Llegaste justo en la epidemia de polio.

DPGB (papá): Fue de lo más duro y de lo más hermoso que vivimos juntos. Los niños llegaban paralizados. Usamos insulina seguida de una fórmula de medicamentos que buscaba frenar la replicación del virus, y trabajamos con químicos de laboratorio para afinar esas soluciones. En varios niños logramos revertir la parálisis. Los periódicos de la época publicaban: "¡Los niños sanan!". Ver a un niño que llegó cargado salir caminando es algo que no se olvida.

DPG (hijo): Papá, uno de esos niños es Salvador Domingo. Le dio polio a los seis años y tú y el abuelo lo trataron. Hace poco me buscó y me contó su historia: el abuelo fue su padrino. No le quedó ninguna secuela de la polio, y en este noviembre de 2026 sigue muy agradecido con ustedes dos.

DPGB (papá): Salvador... Mi padre se encariñaba con sus pacientes, sobre todo con los niños, y no era raro que las familias le pidieran que fuera padrino. Que siga caminando, y que se acuerde, es el mejor regalo que me puedes dar hoy.

DPG (hijo): Y también la maestra Vida Valero Borrás, catedrática de la UNAM, que fue tratada de polio en la clínica. Recuperó totalmente su movilidad.

DPGB (papá): Eso es lo que la gente no entiende cuando habla de curaciones. No es solo el niño que se salva; es todo lo que ese niño hace después. Alguien que recuperó su movilidad terminó enseñando en la universidad.

DPG (hijo): Yo nací el 30 de marzo de 1958. Crecí en ese ambiente.

DPGB (papá): Y por eso te pusimos Donato, igual que a mí y a tu abuelo. No era vanidad; era un compromiso. A tu abuelo lo invitaron a dar conferencias en la Unión Soviética y en Polonia, y en París la radio francesa le dedicó un programa en 1961. En México, en cambio, muchos colegas seguían llamándolo charlatán.

DPG (hijo): El abuelo murió el 12 de diciembre de 1971.

DPGB (papá): De un derrame cerebral, en su clínica, trabajando. Tenía 75 años. Yo tenía 41 y me quedé más solo que nunca. Pero también más decidido que nunca a que su trabajo recibiera el crédito y la credibilidad que merecía. Me prometí que no lo iba a dejar morir con él.

Segunda parte: la ciencia de la llave

DPG (hijo): En los años sesenta tú hiciste tu propia investigación. Tengo aquí tus publicaciones independientes.

DPGB (papá): Quería entender por qué funcionaba lo que hacíamos. Mi padre era un clínico genial, intuitivo. Yo necesitaba medirlo. En 1963 escribí Los efectos bioquímicos de la insulina utilizados en la terapéutica. En 1964 estudié las modificaciones de la tensión superficial producidas por la insulina, y la acción de la insulina sobre los iones de sodio y potasio en la sangre y en la orina, y sobre el pH urinario. En 1965, su acción sobre el CO₂ en la sangre. Cada trabajo era una pieza del mismo rompecabezas: la insulina no solo baja el azúcar. Mueve iones, cambia el pH, cambia la tensión de las membranas. Cambia las constantes de la sangre, como decía tu abuelo.

DPG (hijo): Nadie te publicó en las revistas grandes.

DPGB (papá): Nadie. Las publiqué por mi cuenta y en la revista Impacto, donde durante años fuimos reportando casos: úlceras, hernias hiatales, encefalitis, cáncer gástrico, cáncer de mama. Sabía que no era la forma académica, pero era la forma de que los casos no se perdieran. Hoy esa hemerografía es nuestro archivo.

DPG (hijo): Y no fue casualidad que Impacto publicara esos casos.

DPGB (papá): No. El dueño de la revista era el periodista Don Regino Hernández Llergo, famoso por haber logrado entrevistar a Pancho Villa. Don Regino sufrió un aneurisma de aorta y mi padre fue el médico que lo atendió y lo curó. Don Regino le quedó muy agradecido para siempre, y así se publicó en la propia revista Impacto. Por eso sus páginas estuvieron abiertas a nuestro trabajo cuando las revistas médicas nos cerraban la puerta.

DPG (hijo): Y desarrollaste el Oncodiagnosticador.

DPGB (papá): Mi aparatito. (ríe) Era muy sencillo: un voltímetro y un miliamperímetro. Tomábamos tres centímetros cúbicos de suero del paciente y los poníamos en una bolsita de papel semipermeable, de pergamina, dentro de un vaso con 40 centímetros cúbicos de agua destilada. Dos electrodos delgados de cobre, uno a cada lado, con 32 voltios entre ellos, durante dos horas. Cada quince minutos medíamos temperatura y miliamperaje; al final, el pH. Luego pasábamos el suero a un tubo de vidrio y lo mirábamos contra la luz del día.

DPG (hijo): Y el color hablaba.

DPGB (papá): El color hablaba. Un suero negativo conservaba su color amarillo paja. En los casos positivos aparecía un violeta, desde casi negro hasta muy tenue, y la intensidad nos orientaba sobre el grado del proceso. El café indicaba mucha toxicidad. Yo pensaba que la reacción se debía a alguna fracción proteica, pero siempre fui honesto: mis conclusiones eran empíricas, por correlación clínica. Lo usábamos para seguir a los pacientes cada tres meses después del tratamiento. Siempre dije que alguien con más recursos debería estudiar a fondo esa reacción. Esa invitación sigue abierta.

DPG (hijo): Hay un caso de esos años que pusimos en nuestra primera página de internet en 1996: la niña de tres años con sarcoma de Ewing.

DPGB (papá): La radiografía del brazo izquierdo es de agosto de 1970. Ocho años después, en septiembre de 1978, la radiografía de control mostraba la regresión del tumor, sin cirugía ni radioterapia. Esos son los casos que te sostienen cuando todos te dicen que estás equivocado.

DPG (hijo): Papá, esa niña Monica Gonzalez, sigue viva hoy, en noviembre de 2026. Se casó y tuvo familia.

DPGB (papá): Una niña de tres años con un sarcoma de Ewing, en 1970. Muchos le habían dado unos meses de vida. Y ahora tiene su propia familia. Por casos así vale la pena todo lo demás.

DPG (hijo): Después de la muerte del abuelo, ¿cómo fueron los setenta?

DPGB (papá): Solitarios. La comunidad médica local no me trató mejor que a él. Pero los pacientes agradecidos seguían llegando, y cada uno traía a otro. Y en el otoño de 1975 llegó un médico familiar canadiense, el Dr. Steven G. Ayre. Había oído hablar del tratamiento y vino a la clínica. Trabajó a mi lado todo noviembre de ese año. Regresó a Montreal lleno de entusiasmo y, como nosotros, se encontró con sospecha y burla. Pero no se rindió. Se volvió nuestro amigo y nuestro traductor ante la ciencia anglosajona.

DPG (hijo): Y en 1982 llegué yo.

DPGB (papá): Recibiste tu título y al día siguiente estabas en el consultorio. (ríe) De 1982 en adelante trabajamos juntos, primero hombro con hombro en Ponciano Arriaga y en el Centro Médico Dalinde, después a distancia, cuando te fuiste a Tijuana en 1989. Pero nunca dejamos de trabajar juntos. Hasta el final.

DPG (hijo): Fue una mañana de 1984 cuando te pedí que escribieras tu historia.

DPGB (papá): Me lo dijiste medio en broma, entre paciente y paciente. Pero me quedó la espina. Compré una Macintosh y empecé a escribir mis memorias y a juntar recortes, cartas, oficios, fotografías. Yo no sabía si alguien las iba a leer. Ahora sé que tú las leíste.

DPG (hijo): En 1986 publicamos con Steven Ayre en Medical Hypotheses: "Insulin Potentiation Therapy: a new concept in the management of chronic degenerative disease". Los tres autores: Ayre, Pérez García y Bellón, Pérez García Jr.

DPGB (papá): Fue nuestra primera publicación en una revista científica internacional. Ahí, por fin, quedaron por escrito la historia de tu abuelo y el fundamento: la insulina como modificador de la respuesta biológica, que aumenta la permeabilidad de la membrana y potencia el efecto de los medicamentos. Y algo importante: ya no estábamos solos en la evidencia. En 1981 el Dr. Oliver Alabaster y su grupo, de la Universidad George Washington y del Instituto Nacional del Cáncer de Estados Unidos, habían publicado que la insulina aumentaba hasta diez mil veces el efecto citotóxico del metotrexato en células de cáncer de mama MCF-7 en el laboratorio. Cuando leí eso, pensé en mi padre. Él lo había visto en sus pacientes cuarenta años antes.

DPG (hijo): Y en 1990 el European Journal of Cancer publicó nuestra carta sobre quimioterapia neoadyuvante en dosis bajas con insulina en carcinomas de mama.

DPGB (papá): Ciclofosfamida, metotrexato y 5-fluorouracilo, en dosis reducidas, con la insulina como potenciador. Sin cirugía y sin radioterapia. Recuerdo uno de esos casos: en febrero de 1989 la mamografía mostraba un carcinoma ductal infiltrante con dos ganglios palpables en la axila derecha. En junio de 1989, después de ocho ciclos, las masas habían desaparecido. Conservar el seno de una mujer, conservar su dignidad: eso era lo que tu abuelo había hecho con aquella muchacha en 1946.

DPG (hijo): Y al año siguiente, París.

DPGB (papá): Tercer Congreso Internacional de Quimioterapia Neoadyuvante, febrero de 1991. Steven presentó nuestros casos. Oncology News publicó una nota que decía que la insulina se mostraba prometedora. Mi padre había recibido un homenaje en la radio de París treinta años antes. Yo pensé que por fin el círculo se cerraba.

Tercera parte: "nunca dijimos que no"

DPG (hijo): Octubre de 1989. MD Anderson, en Houston.

DPGB (papá): El Cuadragésimo Segundo Simposio Anual de Investigación Fundamental del Cáncer, del 24 al 27 de octubre. Steven, tú y yo presentamos IPT en una de las instituciones de cáncer más importantes del mundo. Para mí fue como llevar a mi padre de la mano a ese auditorio.

DPG (hijo): Después insististe años con MD Anderson.

DPGB (papá): Años. Escribí, llamé, envié reportes, toqué puertas en Loyola, en Houston. También hablé de IPT con mi amigo Henry Cisneros, en una Navidad en San Antonio; él ofreció su ayuda para promover el estudio científico de la terapia en Estados Unidos. Y persistí con el Dr. Anthony Mastromarino, vicepresidente asistente de investigación de MD Anderson, hasta que aceptaron revisar con sus propios ojos la "terapia mexicana de potenciación con insulina".

DPG (hijo): Y en noviembre de 1996 la Dra. Mary Ann Richardson, del Centro de Investigación en Medicina Alternativa de la Universidad de Texas, vino a mi clínica en Tijuana.

DPGB (papá): Me llamaste esa noche. Me contaste que después de revisar los expedientes dijo: "¡Esto es increíble! ¿Cómo es que nunca se ha hecho nada con esto?". Hijo, esa pregunta yo me la había hecho durante cuarenta años. Ese mismo año pusimos nuestra primera página de internet. Una sola página, con las mamografías y las radiografías de la niña con sarcoma de Ewing.

DPG (hijo): En agosto de 1997 presentamos en los Institutos Nacionales de Salud, en la Oficina de Medicina Alternativa.

DPGB (papá): Y el 18 de septiembre del año 2000 nos volvieron a invitar, a ti, a Steven y a mí, a presentar una serie de mejores casos ante el Panel Asesor de Cáncer del Centro de Medicina Complementaria y Alternativa de los NIH, en Bethesda. Tenía 69 años. Sentí que lo que mi padre empezó en 1930 por fin se escuchaba en el lugar correcto. Ese mismo año publicábamos con Steven otro trabajo en Medical Hypotheses, sobre la insulina, la quimioterapia y los mecanismos de la malignidad.

DPG (hijo): Papá, ¿qué fue lo más duro de todos esos años?

DPGB (papá): Las humillaciones. Que te llamen charlatán. Que se rían de ti en un congreso, como se rieron de mi padre en 1948. Que colegas a quienes enseñaste de buena fe luego quieran adjudicarse lo que no es suyo. Y ver lo que le pasó al Dr. Jean Claude Paquette, en Canadá: practicó IPT con sus pacientes, le fue bien con ellos, y le quitaron su licencia. Murió en 1995. Nos comparábamos con Semmelweis, con Pasteur. No por soberbia; por consuelo.

DPG (hijo): ¿Y por qué no te detuviste?

DPGB (papá): Porque cada mañana había un paciente en la sala de espera. Una señora que no podía mover el brazo, un hombre al que ya habían mandado a su casa a morir. Tu abuelo me enseñó que las etiquetas no significan nada frente a una vida salvada. Nosotros nunca dijimos que no. Ni a un paciente, ni a una idea. Las críticas se las lleva el viento; un paciente que vuelve a comer, a dormir, a tomarse una taza de café sin dolor, eso se queda.

DPG (hijo): En marzo del 2000 vino a entrenarse a mi consultorio el Dr. Ross Hauser, y en octubre el Dr. Robert Rowen, que te llamó por teléfono.

DPGB (papá): Me llamó para decirme que quería organizar un taller para entrenar a médicos en Estados Unidos. Le dije que sí, que contara conmigo. Me hacía mucha ilusión hablarles de mis 44 años de experiencia clínica.

DPG (hijo): El taller fue en Las Vegas, el 21 y 22 de febrero de 2001. Tú ya no llegaste. Moriste el 23 de noviembre del 2000, de un infarto, en tu casa.

DPGB (papá): Lo sé. Pero tú sí llegaste. Y eso era lo importante. La antorcha nunca fue mía; yo solo la cargué un tramo, entre mi padre y tú.

DPG (hijo): Papá, déjame contarte lo que pasó después. En ese seminario de Las Vegas fui profesor. Desde entonces he enseñado IPT en 33 países. En 2002 organizamos el primer congreso sin fines de lucro y, desde entonces, conferencias globales cada año. Hoy cientos de médicos aplican la técnica en todos los continentes. Médicos de Bulgaria publicaron casos de tumores metastásicos tratados con quimioterapia en dosis bajas e insulina; investigadores en China estudiaron cómo la insulina cambia la sensibilidad de células de cáncer de esófago y pulmón a los medicamentos. Hicimos una revisión retrospectiva de 170 expedientes en cinco clínicas. Y en este 2026 se cumplen cien años desde que el abuelo se inyectó por primera vez. Y algo que tú no alcanzaste a ver: me han contactado más de 900 familiares de pacientes. Me buscan y me dicen: "mi papá" o "mi mamá fue paciente de su abuelo", o "de su papá". Eso sigue pasando hoy, en este 2026. Como ellos, en estos cien años de atender enfermos muchos pacientes se recuperaron. Y claro, otros no respondieron al tratamiento. Nunca lo ocultamos.

DPGB (papá): Entonces valieron la pena todas las noches que pasé escribiendo en aquella Macintosh.

DPG (hijo): Una última pregunta. Si tuvieras que decirle algo a los médicos jóvenes sobre la insulina, ¿qué les dirías?

DPGB (papá): Que no la miren solo como la medicina de los diabéticos. La insulina es la hormona que mantiene la estabilidad y la función de la célula para que sigamos vivos. Yo medí apenas unas cuantas de sus acciones: el sodio, el potasio, el pH, el CO₂, la tensión superficial. Seguramente tiene cientos de funciones y acciones químicas que todavía no conocemos. Toda enfermedad, al final, es una alteración dentro de la célula. Y la insulina es la llave para entrar a ella. Ahí, en esa llave, está buena parte de la solución de las enfermedades. Mi padre la encontró. Yo la estudié. Tú y los que vengan tienen que aprender a usarla mejor que nosotros.

DPG (hijo): Feliz cumpleaños, papá.

DPGB (papá): Gracias, hijo. Y no dejes de decir que sí.

DPG (hijo): Papá, déjame terminar con algo que quiero que sepas. En la época que me toca vivir, yo no dependo de los likes en las redes sociales. Tengo lo que muy pocos pueden ofrecer: un legado y una experiencia médica de cien años, con buenos resultados.

Aunque a muchos profesionistas no les parezca, en esta terapia hay mucha ciencia. El tratamiento funciona porque usa los mecanismos fisiológicos de la insulina en la biología y la bioquímica del organismo para tratarlo, corregir la alteración biofísico-química que produce la enfermedad y así lograr la recuperación.

Y finalmente, hoy, en el día de tu cumpleaños, papá, en 33 países hay al menos un médico que se capacitó conmigo para aprender la técnica del abuelo. Y mi reciente ingreso a COLMEDINV va a permitir capacitar a médicos bajo un nuevo formato de Educación Continua, como Diplomado, con el soporte oficial de la SEP y de la Universidad de Morelos. La antorcha sigue encendida.

Nota sobre las fuentes

Esta es una entrevista recreada. Las palabras del Dr. Pérez García Bellón son una reconstrucción hecha con asistencia de IA a partir de los documentos de la familia; los hechos, fechas y cifras provienen de esos documentos. Donde las fuentes difieren, se tomó esta lectura: autoinyección de insulina en 1926 y primer paciente en 1930; experimento con perros hacia 1937 y artículo en la Revista Médica Militar en 1938; ingreso del Dr. Pérez García Bellón a la clínica en 1955 (la cronología dice 1956); congreso de las úlceras en noviembre de 1948 (el compendio dice 1947).

Documentos consultados

  • Cronología de IPT (IPT Chronology of Events)
  • Brief History of Insulin Potentiation Therapy
  • Prólogo, Médico de los desahuciados: La verdadera historia de Insulin Potentiation Therapy (Donato Pérez García III, 2020)
  • Referencias bibliográficas y hemerografía (1930–2012), incluidas las publicaciones independientes de D. Pérez García (2), 1963–1965
  • Oncodiagnosticador: método e interpretación
  • Revista Médica Militar, Tomo I, No. 2, mayo–junio 1938
  • Revista AQUÍ, Hospital Español, No. 115, nov.–dic. 2010, p. 34
  • Ayre SG, Pérez García y Bellón D, Pérez García Jr D. Medical Hypotheses 20(2):199–210, 1986
  • Ayre SG, Pérez García y Bellón D, Pérez García Jr D. European Journal of Cancer 26(11–12):1262–3, 1990
  • Alabaster O, Vonderhaar BK, Shafie SM. Eur J Cancer Clin Oncol 17:1223–1228, 1981
  • Jiao SC et al. Natl Med J China 83(3):195–197, 2003
  • Damyanov C et al. Journal of BUON 14:711–715, 2009
  • Artículos de G. Ayre (páginas web, 2016) y compilación de artículos científicos sobre IPT
  • Primera página web de IPT (1996)
  • IPT/IPTLD Chart Review (170 expedientes, 5 clínicas)
  • Artículo para Cureus (2024), biografía, entrevista del NY Cancer Resource Alliance (2023), folleto Restoring Balance y IPT: 100 Years Legacy and Clinical Compendium (2026)

Meet the IPT Doctor: Dr. Donato Perez Garcia Bellon (1930-2000) my father

An Interview with My Father · November 18, 1930 – November 23, 2000

Dr. Donato Pérez García Bellón
Dr. Donato Pérez García Bellón

Introduction

Today, November 18, my father would have turned 96. Dr. Donato Pérez García y Bellón was born in Mexico City on November 18, 1930, the same year my grandfather successfully treated his first patient with the technique the world would later know as Insulin Potentiation Therapy (IPT). He died at his home in Mexico City on November 23, 2000, five days after his 70th birthday.

I was his son, his student and his colleague. We worked together professionally from 1982, the year I earned my medical degree, until the day he died. In the first years we shared the practice at No. 28 Ponciano Arriaga Street; later, when I moved to Tijuana in 1989, we kept working together at a distance: we wrote papers, presented cases at congresses, travelled to Houston, Paris and Washington, and talked through every difficult case by phone.

I created this interview with the assistance of the AI Claude. The questions are mine. The answers are built from the documents we preserved: his chronology, his publications, the scientific papers we co-authored, the family's press archive, the brief history of IPT, the Oncodiagnosticator method, and the memoirs he began writing on a Macintosh in 1984, after I told him half-jokingly: "You should write your story, Dad; maybe one day our treatment will be practiced all over the world."

I made it to remember the physician who devoted his life to healing thousands of people. Like my grandfather, he never said no. Despite the criticism and the humiliations, both of them kept going with their work. This is his voice, as I remember it and as it remains on paper.

Dr. Donato Pérez García (son) — Tijuana, Baja California, November 18, 2026

The Interview — Part One: the son of the doctor of the hopeless

DPG (son): Dad, let's start at the beginning. You were born on November 18, 1930. What was happening at home that year?

DPGB (father): Something I couldn't have known, but that shaped my whole life. On January 14 of that year your grandfather had successfully treated his first syphilis patient using insulin. I was born ten months later. So, in a way, the therapy and I are the same age. I grew up hearing about insulin at the dinner table, the way other boys heard about football.

DPG (son): How did Grandfather explain where the idea came from?

DPGB (father): He told me many times. Your grandfather was born on October 22, 1896, and joined the army as a private. He studied at the Military College, fought in the Revolution, and was later a founding student of the Military Medical School. He received his medical diploma in July 1924. But he himself was ill: for years he had suffered a gastrointestinal disorder that left him malnourished, nearly skin and bones, and no treatment worked. He had been given up as hopeless.

DPG (son): And then insulin appeared.

DPGB (father): Exactly. Insulin had been discovered in Canada in the early 1920s. Your grandfather was not diabetic, but he read the label carefully: it said insulin was also indicated for malnutrition in non-diabetics. In 1926 he injected himself. First once a day, then before every meal. He began to assimilate his food, regained his weight, and his symptoms disappeared. Then he asked the question that changed everything: if insulin helped my tissues assimilate food, won't it also help them assimilate medicines?

DPG (son): That question is the seed of everything we did afterwards.

DPGB (father): All of it. Your grandfather did not discover insulin, and he never claimed to. What he understood was that insulin is a key: it modifies the permeability of the cell membrane and lets into the cell what could not get in before. He called it "Cellular Therapy through the change of blood constants." The English name, Insulin Potentiation Therapy, came much later, in the mid-1980s, when you and I were working with Dr. Steven Ayre so American physicians could remember it.

DPG (son): What do you remember of the 1930s and 1940s, as a boy?

DPGB (father): I remember my father travelling a great deal and a lot of excitement at home. Around 1937 he worked with the dean of the Faculty of Chemistry, the chemist Rafael Illescas Frísbie, on an experiment in dogs: they showed that with insulin, Salvarsan, the drug used against syphilis, reached the brain better. He published it in the Revista Médica Militar, May–June 1938, as "Cellular permeability as the basis for the radical treatment of syphilis." In 1935 he applied for a U.S. patent, which was granted in 1939. He went to demonstrate his treatment in Austin and San Antonio, Texas, and at St. Elizabeths Hospital in Washington, at the invitation of the U.S. Secretary of War. Patients with neurosyphilis who were considered lost regained their reason.

DPG (son): And then San Diego.

DPGB (father): In 1943 and 1944 he was invited to the Naval Hospital in San Diego, in the middle of the Second World War. He treated American servicemen with malaria, rheumatic fever and cholecystitis, with very good results. TIME magazine ran an article on April 10, 1944: "Insulin for Everything." It was one of the first international recognitions of a Mexican doctor's work. I was thirteen and I remember the newspapers at home. The Mexican papers called him "the wise Dr. Donato Pérez García."

DPG (son): Grandfather also treated many public figures of his time.

DPGB (father): Many. Artists like Palillo came through his office, as did bullfighters and public officials. They arrived ill, sometimes given up as hopeless, and left with their health restored. Many of them stayed grateful to him all their lives and said so publicly. But for my father there was no difference between a famous bullfighter and a private soldier: both were patients and he treated both the same. He had started out as a private soldier himself.

DPG (son): But there were disappointments, too.

DPGB (father): Yes. That same year, 1944, the election did not favor the military group he belonged to, and the chance of his becoming Secretary of Health was gone. Even so, he already had official documents: one from 1939 signed by the head of the Department of Public Health, Alberto P. León, and another from 1940 from the Secretariat of Defense, recognizing the effectiveness of the treatment. In 1941 he was able to open a clinic to test the technique in the army.

DPG (son): And the first cancer case?

DPGB (father): January 1946. A young woman under 24, engaged to be married, the daughter of an army officer. She had breast cancer and was scheduled for a radical mastectomy. Her father's general ordered that she be placed in my father's hands. With insulin and medication he achieved remission without removing her breast. That patient lived free of disease for about thirty more years. This was before medical oncology even existed as a specialty.

DPG (son): And the ulcers, which you always loved to tell about.

DPGB (father): (laughs) Because they mocked him. In November 1948, at the Third Mexican Congress of Medicine at the Hospital General, he presented the medical cure of gastric and duodenal ulcers with bismuth, methylene blue and sulfa drugs, potentiated with insulin. The doctors laughed; they didn't believe him. Decades later it was discovered that ulcers are caused by a bacterium, Helicobacter pylori, and are cured with a mucosal protector and an antibiotic. That was, in essence, what he had done.

DPG (son): When did you decide to become a doctor?

DPGB (father): I don't think I ever decided; I simply became one. In 1953 my father published his book Terapéutica Celular (Cellular Therapy). I was studying medicine in those years and knew it by heart. I graduated in 1955 and went straight to work with him at his clinic in central Mexico City. I never left his side until he died.

DPG (son): You arrived right in the middle of the polio epidemic.

DPGB (father): It was one of the hardest and most beautiful things we lived through together. Children arrived paralyzed. We used insulin followed by a formula of medicines meant to slow the replication of the virus, and we worked with laboratory chemists to refine those solutions. In several children we managed to reverse the paralysis. The newspapers of the day ran headlines like "The children are healing!" Seeing a child who was carried in walk out on his own is something you never forget.

DPG (son): Dad, one of those children is Salvador Domingo. He got polio at six, and you and Grandfather treated him. He reached out to me recently and told me his story: Grandfather was his godfather. Polio left him with no after-effects at all, and this November of 2026 he is still very grateful to you both.

DPGB (father): Salvador... My father grew fond of his patients, especially the children, and it wasn't unusual for families to ask him to be a godfather. That he still walks, and still remembers, is the best gift you could give me today.

DPG (son): And also Professor Vida Valero Borrás, a faculty member at UNAM, who was treated for polio at the clinic. She fully recovered her mobility.

DPGB (father): That's what people don't understand when they talk about cures. It isn't only the patient who is saved; it is everything that person does afterwards. Someone who recovered her mobility went on to teach at the university.

DPG (son): I was born on March 30, 1958. I grew up in that world.

DPGB (father): And that is why we named you Donato, like me and like your grandfather. It wasn't vanity; it was a commitment. Your grandfather was invited to lecture in the Soviet Union and Poland, and in Paris French radio dedicated a program to him in 1961. In Mexico, meanwhile, many colleagues still called him a charlatan.

DPG (son): Grandfather died on December 12, 1971.

DPGB (father): Of a stroke, at his clinic, working. He was 75. I was 41, and I was more alone than ever. But also more determined than ever that his work would receive the credit and credibility it deserved. I promised myself I would not let it die with him.

Part Two: the science of the key

DPG (son): In the 1960s you did your own research. I have your independent publications right here.

DPGB (father): I wanted to understand why what we did worked. My father was a brilliant, intuitive clinician. I needed to measure it. In 1963 I wrote The biochemical effects of insulin used in therapeutics. In 1964 I studied the changes in surface tension produced by insulin, and insulin's action on sodium and potassium ions in blood and urine, and on urinary pH. In 1965, its action on CO₂ in the blood. Each paper was a piece of the same puzzle: insulin doesn't just lower sugar. It moves ions, changes pH, changes the tension of membranes. It changes the constants of the blood, as your grandfather used to say.

DPG (son): None of the big journals published you.

DPGB (father): None. I published them myself and in Impacto magazine, where for years we reported cases: ulcers, hiatal hernias, encephalitis, stomach cancer, breast cancer. I knew it wasn't the academic way, but it was a way to keep the cases from being lost. Today that press archive is our record.

DPG (son): And it was no coincidence that Impacto published those cases.

DPGB (father): No. The magazine's owner was the journalist Don Regino Hernández Llergo, famous for having landed an interview with Pancho Villa. Don Regino suffered an aortic aneurysm, and my father was the physician who treated and cured him. From then on he remained deeply grateful to him, and it was published in Impacto itself. That is why its pages stayed open to our work when the medical journals closed their doors to us.

DPG (son): And you developed the Oncodiagnosticator.

DPGB (father): My little device. (laughs) It was very simple: a voltmeter and a milliammeter. We took three cubic centimeters of the patient's serum and placed it in a small sack of semi-permeable parchment paper, inside a beaker with 40 cubic centimeters of distilled water. Two thin copper electrodes, one on each side, with 32 volts between them, for two hours. Every fifteen minutes we read temperature and milliamperage; at the end, the pH. Then we poured the serum into a glass tube and looked at it against daylight.

DPG (son): And the color spoke.

DPGB (father): The color spoke. A negative serum kept its straw-yellow color. In positive cases a violet appeared, from almost black to very faint, and its intensity guided us on the degree of the process. Brown indicated severe toxicity. I thought the reaction was due to some protein fraction, but I was always honest: my conclusions were empirical, drawn from clinical correlation. We used it to follow patients every three months after treatment. I always said someone with more resources should study that reaction in depth. That invitation is still open.

DPG (son): There's a case from those years that we put on our first web page in 1996: the three-year-old girl with Ewing's sarcoma.

DPGB (father): The X-ray of her left arm is from August 1970. Eight years later, in September 1978, the follow-up X-ray showed the tumor had regressed, without surgery or radiotherapy. Those are the cases that hold you up when everyone tells you you're wrong.

DPG (son): Dad, that little girl is still alive today, in November 2026. She married and had a family.

DPGB (father): A three-year-old girl with Ewing's sarcoma, in 1970. Many had given her a few months to live. And now she has a family of her own. Cases like that make everything else worth it.

DPG (son): After Grandfather's death, what were the seventies like?

DPGB (father): Lonely. The local medical community treated me no better than it had treated him. But grateful patients kept coming, and each one brought another. And in the fall of 1975 a Canadian family physician arrived, Dr. Steven G. Ayre. He had heard about the treatment and came to the clinic. He worked at my side through the whole month of November that year. He went back to Montreal full of enthusiasm and, like us, met with suspicion and ridicule. But he didn't give up. He became our friend and our translator to English-speaking science.

DPG (son): And in 1982 I arrived.

DPGB (father): You got your degree and the next day you were in the office. (laughs) From 1982 on we worked together, first shoulder to shoulder at Ponciano Arriaga and at the Dalinde Medical Center, then at a distance, when you moved to Tijuana in 1987. But we never stopped working together. Until the end.

DPG (son): It was one morning in 1984 that I asked you to write your story.

DPGB (father): You said it half-jokingly, between patients. But it stuck with me. I bought a Macintosh and started writing my memoirs and gathering clippings, letters, official documents, photographs. I didn't know whether anyone would read them. Now I know you did.

DPG (son): In 1986 we published with Steven Ayre in Medical Hypotheses: "Insulin Potentiation Therapy: a new concept in the management of chronic degenerative disease." Three authors: Ayre, Pérez García y Bellón, Pérez García Jr.

DPGB (father): It was our first paper in an international scientific journal. There, at last, your grandfather's story and the rationale were put in writing: insulin as a biological response modifier that increases membrane permeability and potentiates the effect of drugs. And something important: we were no longer alone in the evidence. In 1981 Dr. Oliver Alabaster and his group, from George Washington University and the U.S. National Cancer Institute, had published that insulin increased the cytotoxic effect of methotrexate up to ten thousand-fold in MCF-7 breast cancer cells in the laboratory. When I read that, I thought of my father. He had seen it in his patients forty years earlier.

DPG (son): And in 1990 the European Journal of Cancer published our letter on neoadjuvant low-dose chemotherapy with insulin in breast carcinomas.

DPGB (father): Cyclophosphamide, methotrexate and 5-fluorouracil, in reduced doses, with insulin as the potentiator. No surgery and no radiotherapy. I remember one of those cases: in February 1989 the mammogram showed an infiltrating ductal carcinoma with two palpable nodes in the right axilla. In June 1989, after eight courses, the masses were gone. Preserving a woman's breast, preserving her dignity: that is what your grandfather had done for that young woman in 1946.

DPG (son): And the next year, Paris.

DPGB (father): The Third International Congress on Neoadjuvant Chemotherapy, February 1991. Steven presented our cases. Oncology News ran a piece saying insulin showed promise. My father had been honored on Paris radio thirty years earlier. I thought the circle was finally closing.

Part Three: "we never said no"

DPG (son): October 1989. MD Anderson, in Houston.

DPGB (father): The Forty-Second Annual Symposium on Fundamental Cancer Research, October 24 to 27. Steven, you and I presented IPT at one of the most important cancer institutions in the world. For me it was like walking my father by the hand into that auditorium.

DPG (son): Afterwards you kept after MD Anderson for years.

DPGB (father): Years. I wrote, I called, I sent reports, I knocked on doors at Loyola, in Houston. I also talked about IPT with my friend Henry Cisneros, one Christmas in San Antonio; he offered his help to promote the scientific study of the therapy in the United States. And I persisted with Dr. Anthony Mastromarino, MD Anderson's assistant vice president for research, until they agreed to look with their own eyes at the "Mexican insulin potentiation therapy."

DPG (son): And in November 1996 Dr. Mary Ann Richardson, of the University of Texas Center for Alternative Medicine Research, came to my clinic in Tijuana.

DPGB (father): You called me that night. You told me that after reviewing the charts she said: "This is incredible! How come nothing has ever been done about this before?" Son, I had been asking myself that question for forty years. That same year we put up our first web page. A single page, with the mammograms and the X-rays of the little girl with Ewing's sarcoma.

DPG (son): In August 1997 we presented at the National Institutes of Health, at the Office of Alternative Medicine.

DPGB (father): And on September 18, 2000, they invited us back, you, Steven and me, to make a Best Case Series presentation to the Cancer Advisory Panel of the NIH Center for Complementary and Alternative Medicine, in Bethesda. I was 69. I felt that what my father began in 1930 was finally being heard in the right place. That same year we published another paper with Steven in Medical Hypotheses, on insulin, chemotherapy and the mechanisms of malignancy.

DPG (son): Dad, what was the hardest part of all those years?

DPGB (father): The humiliations. Being called a charlatan. Being laughed at in a congress, the way they laughed at my father in 1948. Colleagues you taught in good faith later trying to claim what isn't theirs. And seeing what happened to Dr. Jean Claude Paquette in Canada: he practiced IPT, his patients did well, and they took away his license. He died in 1995. We compared ourselves to Semmelweis, to Pasteur. Not out of pride; for comfort.

DPG (son): So why didn't you stop?

DPGB (father): Because every morning there was a patient in the waiting room. A woman who couldn't move her arm, a man who had already been sent home to die. Your grandfather taught me that labels mean nothing next to a life saved. We never said no. Not to a patient, not to an idea. Criticism blows away with the wind; a patient who can eat again, sleep again, drink a cup of coffee without pain — that stays.

DPG (son): In March 2000 Dr. Ross Hauser came to train in my office, and in October Dr. Robert Rowen, who phoned you.

DPGB (father): He called to tell me he wanted to organize a workshop to train doctors in the United States. I told him yes, count on me. I was so looking forward to telling them about my 44 years of clinical experience.

DPG (son): The workshop was in Las Vegas, on February 21 and 22, 2001. You didn't make it. You died on November 23, 2000, of a heart attack, at home.

DPGB (father): I know. But you made it. And that was what mattered. The torch was never mine; I only carried it one stretch, between my father and you.

DPG (son): Dad, let me tell you what happened afterwards. At that Las Vegas seminar I was the professor. Since then I have taught IPT in 33 countries. In 2002 we held the first non-profit congress and, since then, global conferences every year. Today hundreds of physicians apply the technique on every continent. Doctors in Bulgaria published cases of metastatic tumors treated with low-dose chemotherapy and insulin; researchers in China studied how insulin changes the sensitivity of esophageal and lung cancer cells to drugs. We did a retrospective review of 170 patient charts from five clinics. And this year, 2026, marks one hundred years since Grandfather first injected himself. And something you didn't live to see: more than 900 relatives of patients have contacted me. They find me and say, "My father" or "My mother was your grandfather's patient," or "your father's." It is still happening today, in 2026. Like them, over these hundred years of caring for the sick, many patients recovered. And of course, others did not respond to treatment. We never hid that.

DPGB (father): Then all those nights I spent writing on that Macintosh were worth it.

DPG (son): One last question. If you had to tell young doctors something about insulin, what would it be?

DPGB (father): Not to see it only as the medicine for diabetics. Insulin is the hormone that keeps the cell stable and functioning so that we stay alive. I measured only a handful of its actions: sodium, potassium, pH, CO₂, surface tension. Surely it has hundreds of functions and chemical actions we still don't know. Every disease, in the end, is an alteration inside the cell. And insulin is the key to get in. In that key lies much of the answer to disease. My father found it. I studied it. You and those who come after must learn to use it better than we did.

DPG (son): Happy birthday, Dad.

DPGB (father): Thank you, son. And never stop saying yes.

DPG (son): Dad, let me end with something I want you to know. In the times I am living in, I don't depend on likes on social media. I have what very few can offer: a legacy and a hundred years of medical experience, with good results.

Even if many professionals don't see it that way, there is a great deal of science in this therapy. The treatment works because it uses the physiological mechanisms of insulin in the body's biology and biochemistry to treat it, correct the biophysical-chemical alteration that produces the disease, and so achieve recovery.

And finally, today, on your birthday, Dad, in 33 countries there is at least one physician who trained with me to learn Grandfather's technique. And my recent admission to COLMEDINV will make it possible to train physicians in a new Continuing Education format, as a Diploma course (Diplomado), with the official backing of Mexico's Ministry of Public Education (SEP) and the University of Morelos. The torch is still burning.

Note on sources

This is a recreated interview. Dr. Pérez García Bellón's words are an AI-assisted reconstruction from the family's documents; the facts, dates and figures come from those documents. Where sources differ, this reading was used: insulin self-injection in 1926 and first patient in 1930; dog experiment around 1937 and the Revista Médica Militar article in 1938; Dr. Pérez García Bellón joining the clinic in 1955 (the chronology says 1956); the ulcer congress in November 1948 (the compendium says 1947).

Documents consulted

  • IPT Chronology of Events
  • Brief History of Insulin Potentiation Therapy
  • Prologue, Médico de los desahuciados: La verdadera historia de Insulin Potentiation Therapy (Donato Pérez García III, 2020)
  • Bibliographic references and press archive (1930–2012), including the independent publications of D. Pérez García (2), 1963–1965
  • Oncodiagnosticator: method and interpretation
  • Revista Médica Militar, Vol. I, No. 2, May–June 1938
  • Revista AQUÍ, Hospital Español, No. 115, Nov.–Dec. 2010, p. 34
  • Ayre SG, Pérez García y Bellón D, Pérez García Jr D. Medical Hypotheses 20(2):199–210, 1986
  • Ayre SG, Pérez García y Bellón D, Pérez García Jr D. European Journal of Cancer 26(11–12):1262–3, 1990
  • Alabaster O, Vonderhaar BK, Shafie SM. Eur J Cancer Clin Oncol 17:1223–1228, 1981
  • Jiao SC et al. Natl Med J China 83(3):195–197, 2003
  • Damyanov C et al. Journal of BUON 14:711–715, 2009
  • G. Ayre articles (web pages, 2016) and compilation of scientific articles on IPT
  • First IPT website (1996)
  • IPT/IPTLD Chart Review (170 charts, 5 clinics)
  • Cureus article (2024), biography, NY Cancer Resource Alliance interview (2023), Restoring Balance brochure and IPT: 100 Years Legacy and Clinical Compendium (2026)

Wednesday, November 11, 2026

Meet the IPT Doctor: Interview with Dr. Alam Barron (November 11, 2026)


 

Interview with Dr. Alam Barrón Barrera 
Low-dose Insulin Potentiation Therapy (IPT): a trajectory Nov 11, 2026 

 
Dr. Donato Pérez García: Alam, dear friend, welcome. To start, tell us who you are and what your background is. Dr. Alam Barrón: Thank you, master, it is an honor to be here with you. My name is Alam Barrón Barrera; I am Mexican, I am 49 years old, and I am a Surgeon and Obstetrician who graduated from the Faculty of Medicine of the Universidad Autónoma de Guadalajara, class of 1997–2001, with professional license number 4009504. 


Dr. Donato Pérez García: How did we meet? 
Dr. Alam Barrón: At the age of 27, as a recently graduated doctor, I had the great opportunity to meet you, who became my instructor and mentor in the training of personalized low-dose Insulin Potentiation Therapy (IPT) at the Hospital Ángeles TJ., BC.MX.
 
Dr. Donato Pérez García: What did that training in IPT mean to you? 
Dr. Alam Barrón: It exceeded all my expectations. It opened a new and broad perspective within conventional medicine and the use of insulin; it is knowledge that is not taught in medical schools. 

Dr. Donato Pérez García: And how have you put it into practice over these years? 
Dr. Alam Barrón: I have applied IPT in degenerative diseases such as cancer, with very satisfactory results and improving the quality of life of my oncology patients. My greatest experience, and the best results I have obtained with low-dose IPT combined with chemotherapy, have been in patients with esophageal, colon, and lung cancer. 

Dr. Donato Pérez García: You have been very close to the international IPT group. Which meetings have you participated in? 
Dr. Alam Barrón: I am still an active member of your IPT group and I have tried to follow in your footsteps at your conferences around the world. I have participated in the International Congress of Low-Dose IPT in Munich, Germany (2010); in Vienna, Austria (2012); in Valladolid, Spain (2022); and in the International Congress of Regenerative Medicine in Mexico City (2023). 

Dr. Donato Pérez García: Besides IPT, what other disciplines have you incorporated? 
Dr. Alam Barrón: Since the beginning of my professional life, I have trained in different techniques of bioregenerative medicine, formerly known as alternative medicine. I also use other biological therapies, such as mesenchymal stromal stem cells, exosomes, and immunotherapies like NK (natural killer) cell therapy. IPT allows me to enhance the effect of these therapies using increasingly lower doses and fewer chemotherapeutic agents. That is why I say that, although conventional medicine may have left it aside, IPT is here to stay. 

Dr. Donato Pérez García: How do you take care of the immune status of your patients? 
Dr. Alam Barrón: It is one of my priorities, in both oncological and non-oncological patients. With low-dose IPT, I seek to stimulate the bone marrow without depressing it, aiming to avoid the immunological damage that frequently accompanies conventional full-dose therapies. 

Dr. Donato Pérez García: Do you use any complementary studies? 
Dr. Alam Barrón: Yes. I have incorporated complementary laboratory studies, such as heavy metal epigenetic tests and hair root epigenetic tests, in order to fine-tune the IPT treatment and support the immune health of the patients. 

Dr. Donato Pérez García: Tell us about a case that left a mark on you. 
Dr. Alam Barrón: I especially remember a 70-year-old female patient with esophageal cancer, cardiac arrhythmias due to uncontrolled hypertension, and uncontrolled diabetes. She had received a terminal diagnosis in medical oncology in La Jolla, California; at the Oncology Hospital of the National Medical Center Siglo XXI in Mexico City; and in La Paz, Baja California Sur. They had given her between two and four months to live. When she arrived at my clinic she could no longer swallow enough food or water, and she presented with mild pain and chronic fatigue. First I treated the arrhythmias and the uncontrolled diabetes; once I confirmed that her condition was suitable to start IPT, I applied the recommended protocol: ten sessions with low doses of chemotherapy and biological medicine. From the second week of treatment, she began to swallow food and water, and the pain disappeared. She lived for two more years with a very good quality of life, without symptoms, until she passed away from sudden cardiac arrest. 

Dr. Donato Pérez García: What did that experience leave you with? 
Dr. Alam Barrón: The greatest satisfaction was that, after everything, her family called me to thank me for those two extra years they had to say goodbye to her. For this, I give glory to God. 
 
Dr. Donato Pérez García: Let's talk a little about you outside the clinic. Where do you live today? 
Dr. Alam Barrón: I was born in Mexico City in 1976 and currently I live in La Paz, Baja California Sur. 

Dr. Donato Pérez García: What place does faith hold in your medical practice? 
Dr. Alam Barrón: A central place. My greatest desire as a person is the salvation of my patients in Christ Jesus. Before starting IPT, I always try to give them hope for life and health: first in their spiritual life and then in their physical life. 

Dr. Donato Pérez García: I know you are a great swimmer. What does swimming give you? 
Dr. Alam Barrón: I swim between 2,000 and 3,000 meters daily; swimming allows me to listen to the silence of the water. Currently, I am preparing to swim in open water in the Sea of Cortez. I also practice weightlifting and high-intensity muscular exercise to promote healthy aging. 
 
Dr. Donato Pérez García: To finish, would you like to say a few words? 
Dr. Alam Barrón: Yes, teacher. This is a part of my story in the life of 

Dr. Donato Pérez García III, who teaches low-dose IPT, and to whom I dedicate these words: God has given him scientific knowledge and, as a wise man, has shaped him. Thank you for sharing it with us; you are a great master and a dear friend. Your legacy has made history. May God continue to bless you. Sincerely, Dr. Alam Barrón B.

Dr. Donato Pérez García: Thank you very much, Alam. It has been a pleasure talking with you. 


November 11, 2026.
 


Thursday, November 5, 2026

Meet the IPT Doctor: Interview with Dr. Martin vonRosen (November 5, 2026)


MEET THE IPT DOCTOR

Dr. Martin von Rosen: Bridging Classical University Medicine and Integrative Care with Low-Dose Targeted IPT

An interview by Dr. Donato Perez Garcia

In this edition of Meet the IPT Doctor, I sit down with a colleague and friend whose career shows what happens when rigorous internal medicine meets an open, curious mind. Dr. Martin von Rosen has practiced medicine since 1996, served as President of the International Association for IPT (IAIPT) from 2018 to 2023, and today leads a clinic for holistic medicine in Germany. We talked about his path, his first encounter with Insulin Potentiation Therapy, and what it took to bring low-dose targeted IPT into everyday practice.

Dr. Martin von Rosen, MD — Specialist in Internal Medicine

Dr. Donato Perez Garcia: Martin, thank you for joining me. Let's start at the beginning. How did your medical career take shape?

Dr. Martin von Rosen: Thank you, Donato, it's a pleasure. I began practicing as a physician in 1996 and specialized in internal medicine. That training in classical university medicine is still my foundation. It taught me discipline in diagnosis, respect for evidence and, above all, to look at the whole patient rather than only one organ or one lab value.

Over the years, though, I kept meeting patients whose needs were not fully met by the standard pathways alone. That pushed me to look further: not away from conventional medicine, but beyond its edges.

Dr. Donato Perez Garcia: When did you first hear about IPT, and what caught your attention?

Dr. Martin von Rosen: My formal introduction came in 2007 in Munich, where I was trained by Dr. Desanka Petricevic-Riedl. What struck me immediately was the physiological logic behind it: using insulin to make cells more receptive, so that medication can be given at considerably lower doses. As an internist, I understood the role of insulin very well, so the concept made sense to me from the very first day.

Later I deepened my training with you, Donato, and learning from the family that developed IPT over three generations gave me a much richer understanding of the method, its history and its fine clinical details.

Dr. Donato Perez Garcia: What does "low-dose targeted" IPT mean to you in practice?

Dr. Martin von Rosen: For me it means precision and respect for the patient. Rather than asking how much a patient can tolerate, we ask how little is needed and how we can direct it as well as possible. Patients who have been through difficult treatments, or who are frail, value an approach that takes their quality of life seriously.

At the same time I'm very clear that IPT is a medical procedure. It requires a trained physician, careful patient selection, close monitoring of blood glucose and a team that knows exactly what it is doing.

Dr. Donato Perez Garcia: Tell us about the day you decided to bring IPT into your own clinic. What was that beginning like?

Dr. Martin von Rosen: After my training I knew this was something I wanted to offer, but I also knew it had to be done properly. So the beginning was very much about preparation: setting up protocols, training my team, defining how we monitor every session and deciding which patients were good candidates.

I still remember the first treatments: a mix of concentration and excitement for everyone in the room. Over time it became an established part of what we do, and it shaped the identity of the whole clinic.

Dr. Donato Perez Garcia: Your clinic combines several approaches. How does IPT fit into that broader philosophy?

Dr. Martin von Rosen: Our clinic is built on holistic medicine. We combine Traditional European Medicine with innovative treatments such as EECP (enhanced external counterpulsation), HBOT (hyperbaric oxygen therapy), Oxyven and IPT, always on the basis of classical university medicine.

IPT is not an isolated tool for us. It sits within an individualized plan that looks at the patient's overall condition: circulation, oxygenation, metabolism, nutrition and lifestyle. The aim is always to support the whole person, not only to treat a diagnosis.

Dr. Donato Perez Garcia: From 2018 to 2023 you served as President of the IAIPT. What did that period teach you?

Dr. Martin von Rosen: It was an honor and a great responsibility. Leading the International Association for IPT gave me the chance to work with colleagues from many countries and see how differently the method is practiced around the world.

My priorities were quality and collaboration: sharing experience openly, promoting proper training and standardized protocols, and building bridges with conventional medicine. A method is only as credible as the physicians who practice it, so education and professional standards must always come first.

Dr. Donato Perez Garcia: What advice would you give a physician who is considering learning IPT?

Dr. Martin von Rosen: First, get proper training from experienced teachers. Second, keep your conventional foundation strong, because your knowledge of internal medicine is what keeps your patients safe. Third, stay humble and keep learning from colleagues. Every patient teaches you something, and an international community like ours is a great resource.

Dr. Donato Perez Garcia: Finally, what keeps you motivated after almost three decades in medicine?

Dr. Martin von Rosen: The patients. When someone tells you they finally feel heard, and that their treatment respects them as a person, that is the best reason to keep going. Combining the best of classical medicine with thoughtful, individualized approaches like low-dose targeted IPT is, for me, what good medicine should look like.

 

Thank you, Martin, for your dedication, your leadership in the IPT community and your commitment to integrating science with a truly patient-centered approach. It's colleagues like you who carry this legacy forward.

— Dr. Donato Perez Garcia

November 5, 2026,

#IPT #InsulinPotentiationTherapy #LowDoseTargetedIPT #IntegrativeMedicine #InternalMedicine #HolisticMedicine #IAIPT #MeetTheIPTDoctor



Thursday, October 22, 2026

Meet the IPT Doctor: Interview with Dr. Roberto Cesar Leite. October 22,2026




Dr. Roberto Cesar Leite
Interview conducted by Dr. Donato Pérez García
Two decades of IPT in Brazil, international exchange, and a friendship between colleagues

Introduction

Some conversations happen out of duty, and others out of affection. This is one of the latter. For many years, Dr. Roberto Cesar Leite and I have shared more than an interest in Insulin Potentiation Therapy (IPT): we have shared classrooms, journeys, conferences and, above all, a friendship that has crossed borders.

Roberto is a physician, a specialist in Medical Nutrology, a doctor in Naturopathy and Nutrition, and coordinator of INTEGRA / SPES Centro de Ensino e Especialização em Saúde Integrada in Brazil. For close to twenty years he has been one of the leading promoters of IPT in his country.

I wanted to conduct this interview to record his journey in his own words, and also to keep, in one place, the memory of what we have lived together as colleagues and friends. What follows is our conversation.

— Dr. Donato Pérez García
The beginnings: training and integrative medicine

Dr. Donato Pérez García: Roberto, dear friend, thank you for agreeing to this conversation. Let's start at the beginning. How did your path in medicine begin?

Dr. Roberto Cesar Leite: Thank you, Donato. It is a great pleasure to do this with you. I graduated in Medicine from the Faculdade Evangélica de Medicina do Paraná in 1986. Very early on I understood that practicing medicine demands constant updating, analytical ability and a willingness to explore different therapeutic perspectives. Medicine does not end with the degree; that is where it begins.

DPG: And you did not stand still. A very broad education followed.
RCL: That's right. I expanded my training with studies in Homeopathy, Acupuncture and Medical Nutrology. In 2003 I earned a doctorate in Naturopathy and Nutrition from Bircham International University in Spain. Each stage gave me different tools to better understand human health.

DPG: What drew you to integrative medicine?
RCL: I was, and still am, interested in the relationships between metabolism, nutrition, physiological processes and complementary therapeutic approaches. Over time, that interest also led me to invest in training professionals and producing educational materials.

DPG: I have always known you as someone who thinks out loud with others, not just for himself.
RCL: I firmly believe that the evolution of medicine depends not only on accumulated experience. It depends on the ability to share knowledge, to dialogue with other professionals and to critically examine the possibilities and limitations of each approach. It was in that context that IPT began to take on an important place in my professional life.
Encountering IPT in Brazil

DPG: Let's talk about IPT. When and how did you come to it?
RCL: About twenty years ago I began working with IPT in Brazil. At that time, spreading it was a real challenge. It required dedication to studying its foundations, contact with experienced professionals and a willingness to go deeper into knowledge that was still little known among many Brazilian physicians.

DPG: What sparked your curiosity?
RCL: I wanted to understand the relationships between insulin, cellular metabolism and the hypotheses behind its use in certain therapeutic contexts. From that interest, I began devoting part of my work to studying IPT, to discussing its protocols and to seeking opportunities for Brazilian professionals to access serious information on the subject.

DPG: I remember you always insisted on knowing the history, not just the technique.
RCL: Because passing on specialized knowledge takes much more than presenting a procedure. You need to know its history, the people who contributed to its development, study its physiological foundations and critically follow the research on its safety and efficacy.
And that is where another important challenge appeared: bringing Brazilian physicians closer to international experience, creating opportunities to learn directly from those who already had years of practice. That initiative became one of the most meaningful dimensions of my journey with IPT.
Our collaboration: a bridge between Mexico and Brazil

DPG: This is where I come into the story. How do you remember the start of our collaboration?
RCL: With great affection, Donato. Among all the professional relationships I built along the way, ours holds a special place. You belong to the third generation of a family historically linked to the development and transmission of IPT. The history of the technique goes back to the work of your grandfather, Dr. Donato Pérez García, Donato I, and continued in the generations that followed. That family history is part of the story I try to preserve and share through teaching.

DPG: And you were determined to bring me to Brazil.
RCL: (Laughs) Yes, I was determined. I recognized the value of direct contact with someone who knew the evolution of IPT from the inside and had international experience. That is why I worked to bring you to Brazil to teach courses on the technique.

DPG: What did those courses mean to you?
RCL: They had a very special meaning. Besides offering learning, they brought Brazilian physicians closer to an international experience that until then had been hard for many of them to reach. Bringing a professional from abroad takes initiative, organization and the conviction that training grows stronger when different experiences are in dialogue. That was the spirit in which we did it.

DPG: And from there something more than a working relationship was born.
RCL: Exactly. Over the years our relationship went beyond the strictly professional and became a friendship built around a love of knowledge, the exchange of experiences and a dedication to teaching. For me it represents the meeting of two professionals, but also a bridge between two countries so that knowledge can flow.

DPG: For me too, Roberto. Few people understand my family's history with the respect you have shown it.
Two encounters we treasure: Austria 2012 and Curitiba 2024

DPG: There are two moments we always bring up when we see each other. The first is Austria.
RCL: Austria, 2012. It was a milestone in our journey. That meeting was captured in photographs that we later included in the IPT educational material developed at SPES. That photo is, for me, a very meaningful memory of our exchange and of the lasting ties we built around the study of the technique.

DPG: What do these international encounters give you?
RCL: They let you learn other perspectives, share experiences and better understand the historical development of a therapeutic approach. But above all, they remind me how important human relationships are in building knowledge. Medicine is an activity deeply shaped by the meeting of people. Many educational initiatives are born precisely from trust, friendship and the desire to share what we have learned.

DPG: Twelve years later we met again in your homeland.
RCL: Yes, at the 1st International Congress of Integrative Medicine Applied to Oncology, in Curitiba, November 14 to 16, 2024. The congress brought together professionals from different fields, with discussions on integrative medicine and exchange between Brazilian specialists and international guests.
Being by your side there again symbolized the continuity of our relationship. Austria and Curitiba are two different moments, but united by the same friendship, the same collaboration and the same interest in the study of IPT. That meeting was also documented in SPES's institutional material.

DPG: Why does organizing spaces like this matter so much to you?
RCL: Because they create learning environments and encourage dialogue among professionals. A congress of that size reflects a concern that has always been with me: that knowledge can be presented, discussed and subjected to critical analysis, respecting the complexity of clinical challenges.

Year &Place.What we remember
2024:Curitiba, Brazil
1st International Congress of Integrative Medicine Applied to Oncology (November 14–16)

2012: Austria
International meeting, captured in photographs in SPES educational material

Over the years: Brazil
IPT courses taught by Dr. Donato Pérez García
Science, responsibility and teaching

DPG: You have always been very clear about IPT's place in clinical practice. How would you explain it today?
RCL: IPT starts from hypotheses about the action of insulin and cellular metabolism, and proposes using it to enhance the action of certain medications in specific contexts. But the proposed mechanisms and clinical results must be analyzed according to the quality of the evidence available for each indication.
This is especially important in oncology. A practitioner's experience can help formulate questions and guide research, but on its own it does not prove efficacy or establish causality.

DPG: What do you consider essential in that debate?
RCL: Analyzing the physiological foundations, the available clinical studies, the risks associated with inducing hypoglycemia and the possible interactions between the medications used. And something I never tire of repeating: patients must be told clearly that IPT should not replace oncology treatments of established efficacy. Any use must be evaluated individually, considering the clinical situation, safety and the relevant evidence.

DPG: That honesty is one of the things I admire most about you. Tell me about SPES and your teaching work.
RCL: Through SPES Centro de Ensino e Especialização em Saúde Integrada, I have devoted myself to organizing content for professionals who want to understand the history, metabolic foundations and clinical issues of IPT. The open course on Insulin Potentiation Therapy is an extension of that work: it covers the historical evolution of the technique, the physiological hypotheses, the protocols described in the literature and what requires attention in clinical evaluation. And your participation, Donato, gives students an international perspective on the history of IPT.

DPG: What does teaching mean to you?
RCL: Sharing knowledge, yes, but also encouraging critical thinking. A responsible course should help people understand the context of a technique, examine its proposals and recognize the questions that remain open. Practitioners must be able to distinguish between clinical experience, physiological hypothesis and scientific proof.

DPG: And you also put all of that in writing.
RCL: I took part in writing the e-book “IPT — Insulin Potentiation Therapies”. It brings together the history of the technique, its physiological and metabolic foundations, the proposed mechanisms, the debates on its clinical use and the protocols described in the literature. It also covers the history of the Pérez García family and our collaboration.
The course and the book complement each other: one is training and exchange; the other, the written organization of knowledge. Both must remain open to updating and critical review, keeping pace with the scientific literature and recognizing the limits of the evidence.
Friendship, memory and legacy

DPG: Roberto, looking back, what place does our friendship hold in your story with IPT?
RCL: A special place. My journey was built not only through study and professional work, but also thanks to the people I met along the way. Our relationship brings together what I consider essential in professional life: mutual respect, a love of knowledge, collaboration and a willingness to share. Austria in 2012, the courses in Brazil and Curitiba in 2024 are moments that document that story, and they show that professional relationships can cross borders and form learning communities.

DPG: Why did you agree to be part of this testimonial project?
RCL: Because preserving the memory of these experiences has value beyond any technique. It means recording how professionals came together, how knowledge was shared and how educational initiatives were built over time. Being able to leave my story alongside those of other physicians who took part in the international history of IPT is a way of recognizing everyone who made this journey possible. I receive your invitation with deep appreciation, Donato.

DPG: How would you define the legacy you want to leave?
RCL: I do not believe a legacy is limited to titles, publications or events. It shows in the learning opportunities we help create, in the relationships we build and in the ability to pass on knowledge responsibly to the next generations. Medicine demands curiosity, intellectual humility and a willingness to revisit ideas. Experience is valuable, but it must go hand in hand with scientific research, clinical responsibility and respect for each patient.

DPG: And if you had to sum it up in one sentence?
RCL: If my path can leave a lasting contribution, I hope it will be remembered for the commitment to sharing knowledge, bringing professionals together and preserving the memory of a journey built through study, collaboration and education. And, if I may add something, also for a friendship that began in a classroom and that time has only made stronger.

DPG: Thank you, Roberto. For your generosity, your rigor and so many years of a shared path. May these pages remain as a memory of what we have built together, and as an invitation to keep doing so.
RCL: Thank you, dear friend. It has been an honor.
 
Dr. Roberto Cesar Leite — Physician | Specialist in Medical Nutrology | Doctor in Naturopathy and Nutrition | Coordinator of INTEGRA / SPES Centro de Ensino e Especialização em Saúde Integrada.


Interview: Dr. Donato Pérez García — October 22, 2026


Meet the IPT Doctor: Donato Perez Garcia (1896-1971) my grandfather the Inventor

Meet the IPT Doctor: The Inventor — Dr. Donato Pérez García (1896–1971)

Meet the IPT Doctor: The Inventor

The systematic accumulation of empirical observations transcends their anecdotal nature to constitute evidence indicative of an underlying phenomenon (IPT: 1926–2026).

Dr. Donato Pérez García in uniform

Dr. Donato Pérez García (1896–1971), military physician, in Mexican Army uniform.

Interviewer's note

This is an imagined interview, but not an invented one. I am Donato Pérez García, M.D., grandson of Dr. Donato Pérez García (1896–1971), the inventor of the therapy that uses insulin to potentiate medicines, known today as Insulin Potentiation Therapy (IPT) and IPTLD. My grandfather died when I was 13. In 2026, a hundred years after his first insulin injection, I decided to sit down with him one last time.

Every answer he gives is built from documents: his Mexican Army service record (Dirección General de Personal, closed on January 31, 1950), the family chronology, the reports in IMPACTO magazine and the newspaper ESTO, the TIME article of April 10, 1944, the Texas and San Diego press, and what my father, Dr. Donato Pérez García Bellón (1930–2000), and I have written on our blogs and websites. Where the documents disagree, I say so in the record notes and in the sources at the end.

The grandson's lines are marked Grandson; my grandfather's, Dr. Pérez García. The [Record note] boxes cite what was written in the army file or in the press of the time.

I. Origins (1896–1914)

Grandson: Grandfather, let's start at the beginning. Where and when were you born?

Dr. Pérez García: I was born on October 22, 1896, in Mexico City. That is the feast day of Saint Donatus, which is where my name comes from. Donato comes from the Latin Donatus: the one who gives. Over the years I understood that the name was also a task.

[Record note: the service record, voucher 92.36, states that he "was born on October 22, 1896, in Mexico, D.F., as he declares in his Autobiography on folio 733 of his file", and adds: "Birth certificate: none". His registration number was 123701, folio 260.]

Grandson: Your file says you had no birth certificate. How so?

Dr. Pérez García: In late-Porfirian Mexico many records were lost, and the Revolution destroyed many more. The Army accepted what I wrote in my own autobiography. So my word became my birth certificate.

Grandson: What was your health like as a child and young man?

Dr. Pérez García: Poor. All my life I suffered from my digestive tract. I ate but did not absorb the food; I was malnourished and weak. No doctor found the cause or the cure. Today you think it may have been Crohn's disease, which nobody in my time knew how to diagnose. That weakness stayed with me until I found the way out myself, years later.

Grandson: And yet at 18 you were a fencing and gymnastics instructor.

Dr. Pérez García: Precisely because of it. Exercise and discipline were my way of fighting a body that would not help me. Fencing teaches you to judge distance, to wait for the moment and not to back down. It served me better in medicine than in the barracks.

Grandson: You also taught yourself English and French.

Dr. Pérez García: There was no other way. The important medical books were in English or French, and many were never translated into Spanish. If I wanted to know what was being discovered in Paris, Toronto or Boston, I had to read it in their language. That decision opened the door to insulin and, later, to Harvard and Washington.

II. The Revolution (1914–1918)

Grandson: You joined the Army in the middle of the Revolution. What was that like?

Dr. Pérez García: I enlisted on October 29, 1914, at 18, as a fencing and gymnastics instructor attached to the "Larraga" Regiment. The country was at war with itself. I wanted to be a doctor, and the Army gave me a way to serve and learn at the same time.

Grandson: A few months later you were already in the medical service.

Dr. Pérez García: On March 15, 1915, I was made second lieutenant, medical aspirant in the Medical Service of the Division of the East. The appointment came with the authorization of the First Chief of the Constitutionalist Army, in charge of the Executive Power, Don Venustiano Carranza. On September 1 that year the Headquarters of the Army Corps of the East promoted me to lieutenant, medical practitioner.

[Record note: the service record lists his service in the Medical Service of the Division of the East, in the Medical Service of General Francisco de P. Mariel's Brigade, and in General Luis Caballero's Brigade "from June 5, 1915 to March 21, 1916".]

Grandson: The family always said you treated the wounded in battles against Pancho Villa's troops.

Dr. Pérez García: That's right. 1915 was the year Constitutionalists and Villistas fought across the whole country. A medical practitioner did everything: sutured, amputated, treated fevers and dysentery without antibiotics and almost without sterile supplies. There I learned that textbook medicine and field medicine are two different things, and that a doctor must solve problems with what he has.

[Record note: the file does not name specific battles. The service against Villa's forces comes from family tradition and the grandson's blogs; the commanders who are recorded, Mariel and Caballero, were Constitutionalist generals operating in eastern Mexico.]

Grandson: In 1916 you asked to be discharged. Why?

Dr. Pérez García: I needed to study. With a war on, there was no way to train properly as a doctor. I requested my discharge and was out of the Army from March 22, 1916 to December 31, 1918. The Army was strict: those two years, nine months and nine days were deducted from my service time when they added up my career in 1950.

[Record note: sheet 8, "Deductions": "The time he was discharged at his own request is deducted", under section I of Article 35 of the Law for the Verification, Adjustment and Computation of Service: 2 years, 9 months, 9 days.]

III. Medical training and army career (1919–1926)

Grandson: In 1919 you went back to the Army.

Dr. Pérez García: On January 1, 1919, I re-enlisted as a cavalry captain, second class. I was assigned to the Cavalry Department but detailed to the Medical Service Department so I could enter the Military Medical School. Later I was detailed to continue my studies at the National School of Medicine. On paper I was a cavalry officer; in practice, a medical student.

Grandson: And while you studied, you kept teaching fencing.

Dr. Pérez García: That is how I earned my pay. On November 11, 1921, I was given the rank of assimilated major on joining the Military College Department, and on February 11, 1922, that of assimilated first captain, provost of the Academies. I was posted to the Inspectorate of the Fencing and Gymnastics Academies. The cadets I trained by day were the same ones I later treated in the infirmary.

Grandson: In 1923 you married my grandmother.

Dr. Pérez García: On May 17, 1923, I married Irene Bellón. She held the household together in the years when I was traveling, being criticized, or short of money. Without her there would have been no cellular therapy. Seven years later our son, your father, was born.

Grandson: And the next year you received your degree.

Dr. Pérez García: On July 21, 1924, I received my diploma as a physician and surgeon. On November 1 that year the War Ministry moved me from the Cavalry to the Medical Service Department as first captain, military physician. My first post as a doctor was chief of the Medical Section of the 19th Line Battalion.

Grandson: What did you specialize in?

Dr. Pérez García: I was a surgeon, mainly in obstetrics, gynecology and urology. I also taught anatomy, physiology and hygiene. Physiology marked me most: it taught me to think about the cell, not just the organ.

Grandson: In 1926 came an important promotion.

Dr. Pérez García: On July 1, 1926, I was promoted to major, surgeon, by agreement of the President of the Republic, after passing the examination required by Article 51 of the Regulations for the Health Service in Peacetime. Soon after I became chief, and later director, of the Military College Infirmary. It was in that office, reading a medical journal, that everything changed.

[Record note: family blogs speak of "Director of the Military Nursing College". The service record says "Chief of the Military College Infirmary" (voucher 35) and "Director of the Military College Infirmary" (vouchers 44–48), that is, the medical service of the Military College.]

IV. The discovery (1926–1930)

Grandson: Tell me about that day in the office.

Dr. Pérez García: I was reading a medical journal and found a short article about a recent breakthrough: insulin, isolated in Toronto by Banting and Best in 1921–1922, with Macleod and Collip. Everyone spoke of it as the cure for diabetes. But the original product labels said something more: it was also indicated to reverse severe malnutrition. I was not diabetic, but I was malnourished.

Grandson: And you decided to try it on yourself.

Dr. Pérez García: In 1926 I injected myself with insulin for the first time. I began with small doses once a day, then before every meal. I began to absorb my food, and the medicines I was taking as well. The digestive trouble went away; I regained weight, appetite and strength. From then on I took insulin before my midday meal every day for the rest of my life, and I never became diabetic.

Grandson: What did you understand at that moment?

Dr. Pérez García: That insulin made my tissues take up better whatever reached them. And I thought: if that happens with food, it can happen with medicines. If insulin opens the door of the cell, the medicine can get in, to where the disorder that causes the disease is. I did not discover insulin. What I saw was that insulin could be the key to the cell membrane.

Grandson: What did you call your method?

Dr. Pérez García: Cellular therapy, or cellular therapeutics by changing the blood constants. The idea was to change the physical and chemical conditions of the blood for a while with insulin, and use that moment to let the medicine act inside the cell. The name Insulin Potentiation Therapy came decades later.

Grandson: Who was your first patient?

Dr. Pérez García: On January 14, 1930, I successfully treated a patient with syphilis of the nervous system, neurosyphilis. There was no penicillin; the treatments of the day were toxic and barely reached the brain. With insulin first and the medicine after, the patient improved. That same year, on November 18, your father was born. For me 1930 was the year of my two children: one of flesh and blood, and the therapy.

Grandson: How did your colleagues react?

Dr. Pérez García: They called me a charlatan, a quack. Nobody then understood the cell membrane, the nucleus or the mitochondria. My answer was that labels meant nothing against a life saved. And I kept treating patients.

[Record note: the family chronology places the self-injection in 1926, and the centennial compendium takes 1926 as the founding date.]

V. Validation and travels (1931–1942)

Grandson: In the 1930s you took your method to the United States. Why there?

Dr. Pérez García: Because in Mexico they didn't believe me, and over there were the hospitals and universities that could see it with their own eyes. On July 13, 1935, I applied for a U.S. patent on my method for treating syphilis. That same year, at 38, I gave a demonstration at Harvard University.

Grandson: Then Texas.

Dr. Pérez García: In 1937 and 1938 I practiced the therapy in San Antonio and Austin. At the Austin State Hospital, a psychiatric hospital, I treated mental and nervous patients. There is a 1937 photograph of me with its superintendent, Dr. C. H. Standifer. The San Antonio Spanish-language daily La Prensa published a piece on June 19, 1938, titled "Cure of Mental and Nervous Diseases".

With the director of the Austin State Hospital, 1937

"With the director of the Austin State Hospital in Texas, in 1937", as the original caption reads. On the left, the hospital superintendent, Dr. C. H. Standifer; on the right, Dr. Pérez García.

Grandson: In Austin you did more than see patients. It was a formal study.

Dr. Pérez García: That's right. The Governor of Texas, James V. Allred, and Dr. Chas. W. Castner of the State Board of Control took an interest in my method, and the Austin State Hospital authorities selected ten patients for a demonstration. All ten had general paralysis of the insane, the form of syphilis that destroys the brain. Almost all had already received malaria therapy, diathermy and the chemical drugs of the day, without success. The goal was single and measurable: to turn the spinal fluid from positive to negative.

Grandson: What did the treatment involve?

Dr. Pérez García: I began on July 30, 1937. I gave nine sessions over about 49 to 51 days, although my technique calls for eight to twelve. Each session was insulin first, then the drugs: neosalvarsan, mercury, bismuth, calcium and iodide. The hospital superintendent, Dr. C. H. Standifer, and his staff helped me, as did Dr. S. W. Bohls, head of the Texas Pasteur Institute.

Grandson: And the results?

Dr. Pérez García: On September 21 Dr. G. M. Graham tested the spinal fluid at his laboratory in the Norwood Building. The next day I gave Dr. Castner my written report. All five cases I was able to treat properly showed a reversed reaction. The most stubborn case gave a doubtful result, with a weakly positive Wassermann, and I recommended repeating the test. Another patient had liver and heart damage; I gave him small doses and he still tested negative. Two patients admitted in August could not complete the treatment, but they improved. I stopped one because he developed a high fever. I could not finish them all because I had to leave for the Eastern States. That trip ended in Washington.

[Record note: the report of September 22, 1937, addressed to Dr. Chas. W. Castner, describes the ten cases with their hospital numbers, prior tests and the September 21 result. The case sheets are headed "Insulin-therapy series treatments by Dr. Donato Pérez García". On September 15, 1937, writing from Kingsville, a member of the Texas State Board of Health (signature illegible) wrote to him at 2107 Neches Street, Austin. He called it an honor to be among the very first in the country to observe his work, asked for the laboratory results and an English translation of his paper, and sent regards to his wife and to Dr. Mendoza. This was a pilot demonstration with no comparison group. Its historical value is as the first documented study of the method outside Mexico.]

Letter from the Texas State Board of Health, September 15, 1937

Letter from a member of the Texas State Board of Health to Dr. Pérez García, Kingsville, September 15, 1937.

Report to Dr. Castner, September 22, 1937

First page of Dr. Pérez García's report to Dr. Chas. W. Castner, Austin, September 22, 1937.

Case sheet, Austin State Hospital, 1937

Sheet for one of the ten cases: prior treatments, laboratory findings, insulin sessions with drugs, and the negative spinal fluid of September 21, 1937.

Grandson: How did you get to Washington?

Dr. Pérez García: In 1938 the U.S. Secretary of War, Harry H. Woodring, invited me to demonstrate the treatment at Saint Elizabeth's Hospital in Washington, the great federal psychiatric hospital. Years later I told that story in IMPACTO, in an article I titled "My Wanderings Through Washington".

Grandson: Meanwhile you were doing research in Mexico.

Dr. Pérez García: In 1937, with the chemist Rafael Illescas Frisbie, head of the University's Faculty of Chemistry, I ran an experiment on dogs. We gave insulin first and the medicine after, and we showed that insulin changed membrane permeability and let substances pass from the blood into the nervous system. We called it the "therapeutic manipulation of cell membrane permeability induced by insulin". In May–June 1938 I published "Cellular permeability as the basis of the radical treatment of syphilis" in the Revista Médico Militar. It was my first article on the method.

Grandson: And official recognition followed.

Dr. Pérez García: In 1939 the U.S. Patent Office granted me patent 2,145,869. That year Mexico's Department of Public Health, headed by Dr. Alberto P. León, signed a document recognizing the treatment's effectiveness (letter 11-848, September 21, 1939). In 1940 the Ministry of National Defense, under General J. Agustín Castro, did the same. That year I presented "Cellular therapeutics by changing the blood constants" at the Second Military Medical Congress and published it as a book.

Grandson: And in the Army?

Dr. Pérez García: On October 1, 1937, I was promoted to lieutenant colonel, surgeon, by presidential agreement. In those years I headed the medical sections of the 1st and 3rd Field Artillery Regiments and of the 44th and 40th Battalions; I served at the Military Teaching Hospital, in the General Staff Department, and twice on detail to the Presidential General Staff. In 1941 I set up a clinic in the Army to test the therapy on soldiers, with good results.

VI. TIME 1944 and the San Diego Naval Hospital (1943–1945)

Grandson: We come to 1944, the TIME year. How did it start?

Dr. Pérez García: With an assignment on the border. I spent seven weeks in the Lower California Military Zone, in Tijuana. There I gave about 155 treatments to 40 patients. One was the wife of General Juan Felipe Rico, the commander, who had gallbladder trouble. Another was a woman paralyzed by tertiary syphilis who walked again after four treatments.

Grandson: And the Navy doctors crossed the border to see you.

Dr. Pérez García: In December 1943 there was a conference in Tijuana on wartime surgery; The San Diego Union reported it on December 29. Doctors from the San Diego Naval Hospital came to hear me and left impressed. They invited me to treat some stubborn cases of malaria and rheumatic fever among their sailors. The malaria patient had no fever after the first session. Of the three rheumatic fever patients, one recovered, one improved, and one refused to continue after the first treatment.

Wilcutts, Rico and Pérez García, 1944

1944. From left: Captain Wilcutts of the U.S. Navy; General Juan Felipe Rico, commander of the Lower California Military Zone; and Dr. Pérez García.

Grandson: And on April 10, 1944, TIME published "Medicine: Insulin for Everything".

Dr. Pérez García: The piece opened by saying "There is a doctor in Mexico City who gives insulin for practically anything". They called me lieutenant colonel, said I was husky and a graduate of the Army School of Medicine. They reported that I had worked with the treatment for 15 years, given about 11,000 treatments without a single death, and kept both my Army duties and a large civilian practice.

TIME cover, April 10, 1944

TIME cover of April 10, 1944 (vol. 43, no. 15), featuring Governor Leverett Saltonstall of Massachusetts. The Medicine section of this issue carried "Insulin for Everything" on Dr. Pérez García.

Grandson: How did they describe your method?

Dr. Pérez García: Quite well, for a weekly magazine. I gave insulin until the patient reached the shock stage: sweating, rapid pulse, loss of consciousness. Then I injected glucose into the vein to reverse the insulin, and the medicine against the disease was mixed into that glucose. A full course was four sessions, five days apart. I believed insulin made the microbes more vulnerable to the drug.

Grandson: TIME also said the naval doctors were still unsure.

Dr. Pérez García: And it was fair to say so. They still did not quite understand how it worked, but they wanted me to come back and do it all again. For a Mexican doctor in 1944, for the U.S. Navy to ask that was a great deal. It was the first international recognition of a Mexican doctor's work in a magazine of that kind.

[Record note: the centennial compendium speaks of 10 soldiers with malaria treated successfully. TIME specifically mentions one malaria patient and three with rheumatic fever.]

Grandson: In Mexico the press followed you all year.

Dr. Pérez García: ESTO published "Eminent work by a distinguished Mexican doctor in the U.S." on March 18, 1944, "A medical glory of Mexico" on April 21, that I had left again for the United States on July 9, and that I had returned on March 10, 1945. I later wrote "Medical success in San Diego" in IMPACTO myself. In October 1945 I presented "The treatment of exanthematic typhus" at the Typhus Congress, and on April 6, 1946, ESTO ran the headline "Typhus has been defeated!". In 1945 I published The Socialization of Medicine in Mexico with Agustín Aragón.

Grandson: People said you might become Minister of Health.

Dr. Pérez García: There was talk of it. But the era of the generals' governments ended, and that possibility ended with it. I did not regret it much: my place was at the patient's bedside.

[Record note: the family chronology says "the military lost the 1944 national elections". Mexico's presidential election was held in July 1946, won by Miguel Alemán, the first civilian president after the Revolution. This date is worth checking.]

VII. Cancer, ulcers and polio (1946–1955)

Grandson: In January 1946 you treated your first cancer case. Tell me about her.

Dr. Pérez García: She was a young woman under 24, engaged to be married, the daughter of an Army officer. She had breast cancer and was scheduled for a radical mastectomy. Her father's commanding general knew of my results and ordered that she be sent to me. I treated her with cellular therapy and she went into remission without losing her breast. Medical oncology did not yet exist as a specialty; in the United States they were only beginning to try nitrogen mustard against leukemia.

Grandson: And almost at the same time, ulcers.

Dr. Pérez García: In those years a gastric or duodenal ulcer was treated with diet, milk or surgery. I healed them with insulin followed by bismuth, methylene blue and sulfa drugs, which were what we had. I presented my cases at a medical congress, and on November 12, 1948, at the Third Congress of Medicine in Mexico City. Many colleagues laughed: they said an ulcer could not be cured with a syringe. In 1950 I presented my results in pyloric stenosis at the Ninth Congress of Surgeons.

Grandson: Decades later it was found that most of those ulcers are caused by a bacterium, Helicobacter pylori, and are cured with antibiotics.

Dr. Pérez García: Your father told me about that, and it doesn't surprise me. I did not know the bacterium, but I did know that with an antimicrobial inside the tissue the ulcer closed. That is the difference between treating the symptom and treating the cause.

[Record note: family texts date the ulcer presentation to 1947 and to 1948 (November 12, Third Congress of Medicine). There may have been two presentations; the 1948 one has an exact date.]

Grandson: In 1948 you became a colonel.

Dr. Pérez García: On November 20, 1948, I was promoted to colonel, surgeon, in the "1948" Promotion of Field and Company Officers, by presidential agreement under Articles 21/c and 71/c of the Law of Promotions and Awards. My last postings were the Military Studies Commission, the Military Health Directorate, the Aeronautics Directorate and the Ministry General Staff. On January 31, 1950, my service record was closed to be sent to the Senate, which ratified colonels' ranks.

[Record note: the record was sent "to the Honorable Senate of the Republic, for the purposes of section II of Article 76 of the Constitution", under letter 01152 of the Personnel Directorate, Third Section, Military Health Desk, dated January 14, 1949. Total time: 35 years, 3 months, 2 days; minus 2 years, 9 months, 9 days of voluntary discharge: "thirty-two years five months twenty-three days" of effective service.]

Dinner given in 1950 for Dr. Pérez García

Dinner given in 1950 for Dr. Pérez García by a group of friends. Per the original caption, from left: Joaquín Valero; chemical engineer Rafael Illescas Frisbie, his partner in the 1937 experiment; Division General F. Durazo; Dr. Donato Pérez García and his wife, Irene Bellón de Pérez.

Luncheon at the Ministry of National Defense
At the table, Ministry of National Defense

Two photographs of a luncheon at the Ministry of National Defense, in the same room.

Grandson: And polio?

Dr. Pérez García: In the late forties polio terrified families. I treated paralyzed children. Nosotros magazine published "The children are healing!" on March 19, 1949, and IMPACTO "Cellular therapeutics in the cure of polio". ESTO returned to the subject on June 16, 1951, with "Against poliomyelitis". In 1955, with your father beside me, we reversed paralysis in children with polio.

Film still: caring for a child in bed

Still from a family film, 1956: two doctors attend a child in bed. Who they are is still to be confirmed.

Grandson: And in 1953, your book.

Dr. Pérez García: Terapia celular (Cellular Therapy). In it I gathered what I had learned in more than twenty years. IMPACTO ran a note on it: "Cellular therapeutics, the new book by Dr. Donato Pérez García".

VIII. Father and son: the final years (1956–1971)

Grandson: In 1956 my father joined your practice.

Dr. Pérez García: It was one of the great joys of my life. Donato, my son, learned the method at my side and improved it. I had the clinical experience; he had a researcher's mind. Two years later, on March 30, 1958, you were born in Mexico City, and I knew a third generation was coming.

Grandson: What did my father research?

Dr. Pérez García: He wanted to measure what I had seen in patients. Between 1963 and 1965 he published his work on the biochemical effects of insulin: changes in surface tension, in sodium and potassium ions in blood and urine, in urinary pH and in blood carbon dioxide. He also developed a simple diagnostic method, the Oncodiagnosticator. And he held that cancer cells have many more insulin receptors than normal cells; he spoke of up to eight times more. That explained why the medicine went mainly to the diseased cell.

Grandson: Together you lectured abroad.

Dr. Pérez García: In Canada, the United States and Europe, before medical societies. IMPACTO published a note on one of my lectures under a title that amused me: "Cellular therapeutics behind the Iron Curtain". Another read "Russia asks, and Mexico gives, the system". Those were the Cold War years, and the interest reached even there.

Grandson: IMPACTO was almost your publishing house.

Dr. Pérez García: For more than twenty years. There I wrote "The great discoveries of modern medical science", "Madmen completely cured", "My wanderings through Washington", "Cure of epilepsy", "A powerful aid to novocaine" (1958) and "Cure of kidney stones". Journalists wrote others: "Mexico's triumph in science" by Álvaro Camino (1958), "It cures cancer" (1959), "Another case of cancer completely cured" (1964) and, in 1967, with your father, "Cellular therapeutics: the story of a medical conquest". On July 10, 1968, came "Mexico launches a medical triumph to the world: the cure of leukemia!". In 1963 El Diario of Delicias, Chihuahua, ran "They cure cancer".

[Record note: these headlines are from the press of the time and reflect its tone. They are historical evidence of what was published, not a present-day medical claim.]

Grandson: What were your days like at the end?

Dr. Pérez García: The same as always: at the clinic, with my patients and my son. I still took my insulin before lunch. In 1971 IMPACTO published "Science in the service of mankind". That is what I had tried to do all my life.

With Dr. Bolaños Cacho and the comedian Palillo

Per the original caption, from left: Cuyo Hernández; Dr. Bolaños Cacho, founder of the Juvenile Court; Dr. D. Pérez García; and the comedian Palillo.

Grandson: (The grandson, closing this chapter) My grandfather died on December 12, 1971, the feast of Our Lady of Guadalupe, at 75, of a stroke, at his clinic in Mexico City. He died where he worked. The following year IMPACTO still published an article under his name: "Cure of a case of breast cancer".

IX. The legacy (1971–2026) and closing words

Grandson: Grandfather, let me tell you what happened afterwards. My father carried on your work. In 1974 he named his version "Donatian Therapy". In 1975 he met Dr. Steven G. Ayre from the United States, and in 1976 Dr. Jean-Claude Paquette from Quebec. In 1986 Ayre gave it the name Insulin Potentiation Therapy and published with us in Medical Hypotheses. In 1989 we presented breast cancer cases at the M. D. Anderson Cancer Center, in 1990 we published in the European Journal of Cancer, and in 1991 we spoke in Paris. New U.S. patents followed in 1990 and 1992.

Dr. Pérez García: And you?

Grandson: I joined my father's clinic in 1982, in the same office you founded. In December of that year I began giving the insulin intravenously. In 1988 I moved to Tijuana, near San Diego, the same border where you made history in 1943. From there I have trained doctors from the Americas, Europe and Asia and organized international conferences. My father died on November 23, 2000. Today the method is called IPTLD, and in 2026 I mark 43 years of practicing it.

Dr. Pérez García: So the key is still opening doors.

Grandson: A hundred years after your first injection. Many children and grandchildren of your patients come to me today because their families still tell how you cured them. Grandfather, what would you say to a young doctor reading this interview?

Dr. Pérez García: Three things. First, observe the patient patiently and write everything down; one observation is an anecdote, but a hundred ordered observations begin to show a truth. Second, do not fear insulin: without insulin there is no life, from the fetus to the old man. You must know it and learn to use it. Third, disease lives inside the cell, and a good doctor looks for the cause, not just the symptom.

Grandson: That is what we meant by the subtitle of this interview.

Dr. Pérez García: I know. They called me a charlatan and left me alone at some congresses. But patients came back healthy, and every case was written down. The systematic accumulation of observations stops being anecdote and becomes evidence that something real is happening. Let today's science keep studying it. That is what I worked for.

"Labels mean nothing against a life saved." — Dr. Donato Pérez García, as remembered by his family.

Chronology 1896–1971

Dr. Donato Pérez García's life in 45 dates, oldest first. SR = Army service record.

Date Event Source
Oct 22, 1896 Born in Mexico City, on the feast of Saint Donatus SR, folio 733
Oct 29, 1914 Enlists: fencing and gymnastics instructor, "Larraga" Regiment SR
Mar 15, 1915 Second lieutenant, medical aspirant, Medical Service of the Division of the East SR
Jun 5, 1915 – Mar 21, 1916 Gen. Luis Caballero's Brigade (earlier, Gen. Francisco de P. Mariel's Brigade) SR
Sep 1, 1915 Lieutenant, medical practitioner, Army Corps of the East SR
Mar 22, 1916 – Dec 31, 1918 Discharged at his own request SR
Jan 1, 1919 Re-enlists: cavalry captain, second class, detailed to the Military Medical School SR
Nov 11, 1921 Assimilated major, Military College SR
Feb 11, 1922 Assimilated first captain, provost of the Academies SR
May 17, 1923 Marries Irene Bellón Family chronology
Jul 21, 1924 Receives his medical degree Family chronology
Nov 1, 1924 First captain, military physician; Medical Section, 19th Battalion SR
Jul 1, 1926 Major, surgeon, by examination (Art. 51) SR
1926 First self-injection of insulin Family chronology
Jan 14, 1930 First patient treated: neurosyphilis Family chronology
Nov 18, 1930 Son Donato Pérez García Bellón born Family chronology
Jul 13, 1935 Applies for U.S. patent (syphilis) Family chronology
1935 Demonstration at Harvard University Family chronology
1937 Dog experiment with Rafael Illescas Frisbie (permeability, blood-brain barrier) Family texts
1937–1938 Practices in San Antonio and Austin, Texas; pilot study of 10 neurosyphilis patients at the Austin State Hospital (Jul 30 – Sep 22, 1937) Family chronology
Oct 1, 1937 Lieutenant colonel, surgeon SR
May–Jun 1938 Article in Revista Médico Militar on cell permeability and syphilis Bibliography
Jun 19, 1938 La Prensa (San Antonio): piece on mental and nervous diseases Bibliography
1938 Invited by Secretary of War Harry H. Woodring to Saint Elizabeth's Hospital, Washington Family chronology
1939 U.S. patent 2,145,869 Family chronology
Sep 21, 1939 Recognition by the Department of Public Health (letter 11-848, Alberto P. León) Bibliography
1940 Recognition by the Ministry of Defense (J. Agustín Castro); book and paper at the 2nd Military Medical Congress Chronology, bibliography
1941 Clinic to test the therapy in the Army Family chronology
Dec 29, 1943 The San Diego Union reports the Tijuana conference Bibliography
1943–1944 Treatments at the San Diego Naval Hospital Chronology, TIME
Apr 10, 1944 TIME publishes "Medicine: Insulin for Everything" TIME
Oct 1945 "The treatment of exanthematic typhus", Typhus Congress Bibliography
Jan 1946 First breast cancer patient treated Family chronology
May 28, 1947 San Antonio Express: "Doctor Battles Disease with Insulin Treatments" Bibliography
Nov 12, 1948 Presents ulcer results, Third Congress of Medicine Family chronology
Nov 20, 1948 Colonel, surgeon, "1948" Promotion SR
Mar 19, 1949 Nosotros: "The children are healing!" (polio) Bibliography
Jan 31, 1950 Service record closed for the Senate: 32 years, 5 months, 23 days of effective service SR
1950 Presents pyloric stenosis results, 9th Congress of Surgeons Family chronology
1953 Publishes Terapia celular Family chronology
1955 With his son, reverses polio paralysis in children Family chronology
1956 His son joins the practice Family chronology
Mar 30, 1958 Grandson Donato Pérez García born Family chronology
1967 IMPACTO: "Cellular therapeutics: the story of a medical conquest" Bibliography
Dec 12, 1971 Dies of a stroke at his clinic, aged 75 Family chronology

The service record

The file of the Personnel Directorate (Service Records Office) records 10 ranks in 34 years, from fencing instructor to colonel, surgeon.

Date Rank or post How it was conferred
Oct 29, 1914 Fencing and gymnastics instructor On enlisting, attached to the "Larraga" Regiment
Mar 15, 1915 Second lieutenant, medical aspirant Authorized by the First Chief of the Constitutionalist Army
Sep 1, 1915 Lieutenant, medical practitioner Headquarters, Army Corps of the East
Jan 1, 1919 Cavalry captain, second class On re-enlisting, by the Ministry
Nov 11, 1921 Assimilated major On joining the Military College
Feb 11, 1922 Assimilated first captain, provost of the Academies By the Ministry
Nov 1, 1924 First captain, military physician Moved from Cavalry to the Medical Service
Jul 1, 1926 Major, surgeon Presidential agreement, after examination (Art. 51)
Oct 1, 1937 Lieutenant colonel, surgeon Presidential agreement, field officers' promotion
Nov 20, 1948 Colonel, surgeon Presidential agreement, "1948" Promotion

Main postings: Medical Service of the Division of the East; Generals Mariel's and Caballero's brigades; Military Medical School and National School of Medicine; Health Department; Inspectorate of the Fencing and Gymnastics Academies; medical sections of the 19th, 40th and 44th Battalions and of the 1st and 3rd Field Artillery Regiments; Military College Infirmary (chief and director); Military Teaching Hospital; General Staff Department; Presidential General Staff; General Directorate of Military Education; Military Studies Commission; Military Health Directorate; Aeronautics Directorate; Ministry General Staff.

Evaluations by his commanding officers (vouchers 7, 8, 12, 84, 85, 109 and 110): correct conduct and gentlemanliness that earned him his superiors' esteem; honest and dutiful in his rank and assignment; with the knowledge needed for his duties; of great competence, dedication and zeal, with "military as well as civilian conduct beyond reproach".

Length of service: 35 years, 3 months and 2 days (Oct 29, 1914 – Jan 31, 1950), minus 2 years, 9 months and 9 days of voluntary discharge = 32 years, 5 months and 23 days of effective service.

Photographs of the record

Eight scanned sheets from the original file, in the order they are kept: autobiography and registration number; ranks and dates (two sheets); units served in (four sheets, with the computation of service time); and commanding officers' evaluations.

Service record: autobiography

1. Autobiography (voucher 92.36): born October 22, 1896, in Mexico City; registration no. 123701, folio 260.

Service record: ranks and dates 1914–1926

2. Ranks and dates obtained, 1914–1926: from fencing instructor to major, surgeon.

Service record: ranks and dates 1937–1948

3. Sheet 4: lieutenant colonel (October 1, 1937) and colonel, surgeon (November 20, 1948).

Service record: units served in, 1914–1924

4. Units served in: "Larraga" Regiment, Division of the East, Mariel and Caballero brigades, voluntary discharge, Military Medical School.

Service record: units served in, continued

5. Units, continued: Military College Infirmary, Military Teaching Hospital, Presidential General Staff, artillery regiments.

Service record: units and closing

6. Units, final sheet: Military Studies Commission, Military Health, Aeronautics; file closed January 31, 1950 for the Senate.

Service record: computation of service

7. Computation: 35 years, 3 months, 2 days, minus 2 years, 9 months, 9 days = 32 years, 5 months, 23 days of effective service.

Service record: commanding officers' evaluations

8. Evaluations by the commanding officers he served under: "military as well as civilian conduct beyond reproach".

Sources and notes on dates

Family documents

  • Mexican Army service record, Personnel Directorate, closed January 31, 1950 (eight sheets photographed, above).
  • Insulin Potentiation Therapy: Chronology of Events and Cronología (Pérez García family).
  • History of IPT and Here is the story of a pioneer, by Dr. Donato Pérez García (grandson).
  • IPT 100 Years: Legacy and Clinical Compendium, Dr. Donato Pérez García, 2026.
  • Referencias bibliográficas: the list of articles from IMPACTO, ESTO, La Prensa, The San Diego Union, San Antonio Express, Nosotros, Revista Médico Militar and books cited in this interview.
  • 1937 Austin State Hospital Pilot Study with Insulin Potentiation Therapy in the Treatment of Tertiary Neurosyphilis: letter of September 15, 1937, report of September 22, 1937, and the ten case sheets (14 pages).

Online sources consulted

donatoperezgarcia.com and the Facebook page could not be read: their servers block automated access. Some label pages of the iptld blog could not be read either.

Dates that differ between sources

Item Version A Version B In this interview
First insulin self-injection 1926 (chronology, compendium) 1930 (blog, 2015) 1926
U.S. patent 2,145,869 Granted 1939 (chronology) 1938 (History of IPT) 1939
Ulcer presentation 1947 (compendium, Here is the story) Nov 12, 1948 (chronology) Both
End of the Health Ministry prospect "1944 elections" (chronology) The presidential election was in 1946 No year, with note
Life dates 1896–1971 (chronology, SR) 1896–1970 (LinkedIn, Here is the story) 1896–1971
Malaria in San Diego 10 soldiers (compendium) 1 malaria and 3 rheumatic fever patients (TIME) What TIME says
Post at the Military College "Director of the Military Nursing College" (blog) "Director of the Military College Infirmary" (SR) What the SR says

This interview is an exercise in historical memory. Dr. Pérez García's answers reconstruct what documents and testimony say about him; they are not recorded words.

© Dr. Donato Pérez García · IPT 1926–2026

Meet the IPT Doctor: Dr.Donato Perez Garcia Bellon (1930-2000) mi padre.

Entrevista con mi padre · 18 de noviembre de 1930 – 23 de noviembre de 2000 Dr. Donato Pérez García Bellón 18 de noviembre de 2026 Pre...